Identification of an immunogenic Mannheimia haemolytica immunoglobulin-, fibronectin- and fibrinogen-binding protein differentially expressed in vitro by Osmundson, Ruth Smith
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2003
Identification of an immunogenic Mannheimia
haemolytica immunoglobulin-, fibronectin- and
fibrinogen-binding protein differentially expressed
in vitro
Ruth Smith Osmundson
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Immunology and Infectious Disease Commons, Medical Immunology Commons,
Microbiology Commons, and the Veterinary Medicine Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Osmundson, Ruth Smith, "Identification of an immunogenic Mannheimia haemolytica immunoglobulin-, fibronectin- and fibrinogen-
binding protein differentially expressed in vitro " (2003). Retrospective Theses and Dissertations. 610.
https://lib.dr.iastate.edu/rtd/610
NOTE TO USERS 
This reproduction is the best copy available. 
® 
UMI 

Identification of an immunogenic Mannheimia haemolytica immunoglobulin-, 
fibronectin- and fibrinogen-binding protein differentially expressed in vitro 
by 
Ruth Smith Osmundson 
A dissertation submitted to the graduate faculty 
in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
Major: Immunobiology 
Program of Study Committee: 
Louisa B. Tabatabai, Co-major Professor 
James A. Roth, Co-major Professor 
Joan E. Cunnick 
James S. Dickson 
Merlin L. Kaeberle 
Iowa State University 
Ames, Iowa 
2003 
UMI Number: 3085935 
UMI 
UMI Microform 3085935 
Copyright 2003 by ProQuest Information and Learning Company. 
All rights reserved. This microform edition is protected against 
unauthorized copying under Title 17, United States Code. 
ProQuest Information and Learning Company 
300 North Zeeb Road 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346 
11 
Graduate College 
Iowa State University 
This is to certify that the doctoral dissertation of 
Ruth Smith Osmundson 
has met the dissertation requirements of Iowa State University 
Co-major Profess 
Co-major Professor 
For the Major Program^ 
For the G auate College 
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
Ill 
DEDICATION 
To my children, 
Anna Smith Osmundson 
and 
Caleb Smith Osmundson: 
Reach for your stars! 
iv 
TABLE OF CONTENTS 
ABSTRACT vii 
CHAPTER 1. GENERAL INTRODUCTION 1 
Dissertation Organization 5 
Literature Review 6 
Mannheimia haemolytica 6 
Taxonomy 6 
Physical characteristics 7 
Bovine Respiratory Disease 7 
Etiology and epidemiology 7 
Pathogenesis 8 
Virulence factors 11 
Leukotoxin 11 
Lipopolysaccharides 12 
Capsular polysaccharide 12 
O-sialoglycoprotease 13 
Neuraminidase 13 
Fimbrae 14 
Iron-regulated Proteins 14 
Vaccines 15 
History 16 
Bacterins 16 
Live vaccines 16 
Subunit vaccines 17 
Growth condition dependent protein expression 18 
Immunoglobulin-binding proteins 20 
History 20 
Protein A 21 
Immunoglobulin-binding protein classification 21 
Immunoglobulin-binding protein binding specificity 22 
Immunoglobulin-binding proteins and virulence 23 
Superantigens 23 
Mitogens 24 
Complement activation and inhibition 25 
Antiphagocytes 25 
Antibody-dependent cellular cytotoxicity inhibition 25 
Virulence in vivo 25 
Therapeutic use of immunoglobulin-binding proteins 26 
Extracellular matrix-binding proteins (ECMBPs) 27 
Extracellular matrix proteins (ECMPs) 27 
Fibronectin 27 
Fibrinogen 28 
V 
Extracellular matrix-binding proteins 28 
Identification 28 
Virulence association 29 
Vaccine potential 31 
References 32 
CHAPTER 2. IDENTIFICATION AND CHARACTERIZATION OF AN 50 
IMMUNOGLOBULIN-BINDING PROTEIN EXPRESSED BY MANNHEIMIA 
Abstract 50 
Introduction 51 
Materials and Methods 54 
Bacterial isolates 54 
Whole cell sonicate and supernatant preparations 54 
Gel electrophoresis and immunoblotting 55 
Bovine antisera 55 
Affinity isolation 56 
Flow cytometry 56 
Results 57 
Identification of M. haemolytica IgBP(s) 57 
Isolation of M. haemolytica IgBP(s) 57 
Surface expression of M. haemolytica IgBP(s) 58 
Humoral immunogenicity of M. haemolytica IgBP(s) 58 
Involvement of IgBP(s) from different serotypes with species-specific 58 
infection 
Discussion 59 
References 64 
Figures and figure legends 69 
CHAPTER 3. FIBRINOGEN- AND FIBRONECTIN-BINDING AND IN VITRO 75 
GROWTH CONDITION-DEPENDENT EXPRESSION OF A MANNHEIMIA 
HAEMOLYTICA IMMUNOGLOBULIN-BINDING PROTEIN 
Abstract 75 
Introduction 76 
Materials and Methods 80 
Bacterial isolate and growth conditions 80 
Fetal bovine sera 80 
IgBP isolation 80 
Gel electrophoresis and immunoblotting 80 
WCS and membrane protein preparation 81 
2-D gel electrophoresis 82 
2-D gel analysis 83 
vi 
Results 83 
M. haemolytica growth in different in vitro growth conditions 83 
M. haemolytica IgBP also binds fibrinogen and fibronectin 84 
Comparative analysis of total IgBP pixel density 85 
Comparative analysis of individual spot pixel density 86 
Discussion 87 
References 90 
Figures and figure legends 93 
Tables 1 and 2 97 
CHAPTER 4. GENERAL DISCUSSION AND CONCLUSIONS 98 
Table 1 105 
Table 2 106 
References 108 
ACKNOWLEDGMENTS 110 
Vil 
ABSTRACT 
Bovine respiratory disease (BRD), or "shipping fever", is the cause of large losses to 
the cattle industry annually and is primarily caused by Mannheimia haemolytica serotype 
(ST) 1. M. haemolytica, a normal flora respiratory tract bacterium, rapidly multiplies upon a 
stressful occurrence and colonizes the upper respiratory tract. This can lead to 
fibrinohemorrhagic pneumonia. Bacterial immunoglobulin-binding protein (IgBP) 
expression is known to play a role in the pathogenesis of a variety of organisms. Far-
Western blot was used to demonstrate the presence of an IgBP(s) in whole cell sonicates 
(WCSs) and a culture supernatant (CS) preparation from M. haemolytica ST 1. The IgBP(s) 
was isolated by affinity chromatography and used in a far-Western blot to show that the 
IgBP(s) also binds the extra-cellular matrix proteins (ECMPs) fibrinogen and fibronectin. 
ECMPs are known to play a role in colonization of some bacteria by acting as a bridge 
enabling binding between bacteria expressing extracellular matrix-binding proteins and 
epithelial cells. Flow cytometry showed the surface expression of an IgBP(s) on whole cell 
M. haemolytica. Immune sera from convalescent cattle showed an increased antibody 
response to the 75.0 kDa IgBP when compared to sera from naive or acutely infected cattle 
as seen by Western blot. It was demonstrated that all 12 serotypes (1,2, 5-9, 12-14, and 16) 
bound both bovine Fc IgG and sheep Fc IgG. Significant differences were not found 
between ST1, most frequently isolated in infections in cattle and ST2, isolated predominantly 
in sheep mannheimiosis. The effect of various M. haemolytica growth conditions on IgBP(s) 
expression was assessed by 2-D gel electrophoresis analysis. Membrane expression of M. 
haemolytica IgBP(s) was increased three-fold when M. haemolytica was grown in RPMI-
1640 with 10%FBS and in RPMI-1640 at 40°C and increased two-fold when grown in 
RPMI-1640 with 50 jaM 2,2'-dipyridyl when compared to growth in RPMI-1640 at 37°C. 
The IgBP(s) constituted up to 19.9% of M. haemolytica membrane proteins when M. 
haemolytica was grown in RPMI at 40°C. It is a highly expressed protein when M. 
haemolytica is grown under conditions mimicking factors of the in vivo environment. This 
study shows a possible role in virulence for the M. haemolytica IgBP. It is immunogenic, 
surface expressed and as an IgBP it may enable M. haemolytica to evade the host immune 
response and may play a role in colonization through binding fibronectin or fibrinogen. 
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CHAPTER L GENERAL INTRODUCTION 
Bovine respiratory disease (BRD) or "shipping fever" is believed to result in the 
single largest loss annually to the cattle industry. BRD has a complex etiology but 
pulmonary fibrinous pneumonia, the ultimate cause of severe clinical disease and death, is 
primarily caused by Mannheimia haemolytica (Houghton and Gourlay, 1984). M. 
haemolytica serotype ST2 is a normal flora bacteria of the upper respiratory tract (URT) in 
cattle but on occurrence of a stressful incident such as viral infection or shipping from farm 
to feedlot, isolates of M. haemolytica shift from ST2 to ST1 and can grow explosively 
colonizing the URT (Frank 1979; Frank and Smith, 1983). The bacteria are believed to be 
inhaled into the lung resulting in macrophage activation and pulmonary serum flooding. An 
influx of neutrophils along with an M. haemolytica secreted leukotoxin exacerbates the 
response. This leads to lung lesions characteristic of M. haemolytica-induced 
fibrinohemorrhagic pneumonia. Some animals are able to recover while others succumb to 
pneumonic mannheimiosis (Whitely et al., 1992). 
A number of vaccines are available for M. haemolytica induced BRD. Bacterins 
provide protection of variable efficacy. A number of experimental trials have even shown an 
exacerbation of BRD in bacterin vaccinates (Friend et al., 1977; Wilkie et al., 1980). While 
live vaccines generally perform better in field-tests than bacterins (Confer et al., 1985b), live 
vaccines still have variable efficacy with some trials showing no increased protection due to 
immunization (Purdy et al., 1986). Live vaccines have inherent problems with production 
and stability. While not providing full protection, bacterial component vaccines have 
demonstrated the importance of leukotoxin (Conlon et al., 1991), iron binding proteins 
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(Potter et al., 1999) and surface antigens (Shewen et al., 1988) in protection. There is a need 
for a more efficacious vaccine. 
M. haemolytica expresses a number of known virulence factors. The best 
characterized is a leukotoxin (Kaehler et al., 1980), a member of the RTX toxin family. 
Other virulence factors include the capsular polysaccharide (Carter, 1956), LPS (Rimsay et 
al., 1981), fimbrae (Morck et al., 1987; Potter et al., 1988), iron-regulated proteins, 
(Donachie and Gilmour, 1988), neuraminidase (Frank and Tabatabai, 1981) and O-
sialoglycoprotease (Abdullah et al., 1992). This study demonstrated the presence of an 
additional M. haemolytica virulence factor, an immunoglobulin-binding protein (IgBP). 
IgBPs have been identified in a number of other Gram-positive and Gram-negative 
bacteria. Surface expressed protein A from Staphylococcus aureus Cowan 1 is the first IgBP 
identified (Forsgren and Sjôquist, 1966). Protein A is known inhibits phagocytosis and IgBP 
surface expression is responsible for this inhibition (Dosset et al., 1969). Protein A in 
solution fixes complement by forming IgG:protein A complexes (Langone et al., 1978) and 
to inhibit antibody-dependent cellular cytotoxicity (Rosenblatt et al., 1977). Acting as a B 
cell superantigen, protein A activates complement (Kozlowski et al., 1996), induces 
expression of Ig from the VH3 gene family (Kristiansen et al., 1994), increases antigen 
presentation through soluble protein A:Ig complexes associated with VH3 family surfaced 
expressed immunoglobulins (Leonetti et al., 1999) and is involved in inflammation as 
demonstrated by the elicitation of an Arthus reaction through administration of soluble 
protein A:Ig complexes (Kozlowski et al., 1998). In vivo experiments indicate a role for 
IgBPs in virulence. Mice injected with an S. aureus protein A deletion mutant require a 
marginally higher dose of the mutant for inactivity and take significantly longer to succumb 
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to infection and die at a slightly decreased rate than mice infected with S. aureus expressing 
protein A (Patel et al., 1987). These results may have been more dramatic if a second more 
recently identified S. aureus IgBP, Sbi, had also been deleted (Zhang et al., 1998). These 
experiments demonstrate a role for IgBPs in virulence although their role has not been clearly 
elucidated. 
Most bacteria initiate infection by binding to host cells. Bacterial cell surface 
components adhere to host cell components or to host extracellular matrix (ECM) proteins 
that bind host cells and act as a bridge between bacteria and host cells. Extracellular matrix-
binding proteins (ECMBPs) from Staphylococcus aureus are best characterized and include 
proteins that bind fibronectin (Fn), collagen (Cn) and a secreted protein that binds fibrinogen 
(Fg) (Flock, 1999). A number of Gram-negative organisms express ECMBPs including 
Eschericia coli (Westerland et al., 1989), Haemophilus ducreyi (Abeck et al., 1992), H. 
influenza (Fink et al., 2002), Neisseria gonorrhoeae (van Putten et al., 1998) and Borellia 
burgdorferi (Probert and Johnson, 1998). In vitro models demonstrate several additional 
roles for ECMBPs in virulence. In the presence of Fn and an anti-CD3 monoclonal antibody. 
S. aureus fibronectin-binding protein A (FnbpA) mediates adhesion to T cells and T cell 
costimulation through the T cell asPi integrin, which binds fibronectin and functions as a 
costimulatory molecule, leading to T cell activation (Miyamoto et al., 2001). A T helper type 
2 inflammatory environment promotes S. aureus binding to skin and this binding is mediated 
by Fn and Fg (Cho et al., 2001a). ECMBPs appear to have a variety of roles in virulence. 
The surface components used by M. haemolytica to adhere to airway epithelial cells 
are not known. Two types of fimbrae, a large, rigid fimbrae (Morck et al., 1987) as well a 
smaller, flexible fimbrae (Potter et al., 1988) have been reported. However, several 
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investigators have been unable to demonstrate the presence of fimbrae on newly isolated 
M. haemolytica ST1 using the same procedures (Gonzalez and Maheswaran, 1993) and 
fimbrial adhesion has not been demonstrated for M. haemolytica. Identification of an M. 
haemolytica adhesive surface component would open the door to development of a treatment 
that could decrease colonization and result in reduced development of pneumonic 
pasteurellosis. 
The mechanism for the abrupt change from the predominance of the normal flora M. 
haemolytica ST2 to explosive growth of stress-associated ST1 is not known. However, 
change in host environmental factors due to stress is likely to play a role. In an effort to 
recreate in vivo protein expression while using in vitro systems and also to define culture 
conditions that affect expression of particular proteins, a number of studies have been done 
to define protein expression under different culture conditions. Pathogens are known to up-
regulate or down-regulate expression of adhesive components under varying conditions of 
the host environment (Finlay and Falkow, 1989; Francis et al., 1989; and Mekalanos, 1992). 
Shewen and Wilkie (1982) reported that the addition- of 7% fetal bovine serum (FBS) to 
RPMI-1640 tissue culture media achieves enhanced M. haemolytica leukotoxin production 
compared to tissue culture media alone. Iron-regulated outer membrane proteins of 71, 77 
and 100 kDa are expressed at higher levels in iron-restricted media (Deneer et al., 1989; 
Morck et al., 1991). No capsular polysaccharide production is detected when M. 
haemolytica is grown above 40°C (Puente-Polledo et al., 1998). Establishing in vitro 
growth conditions that closely mimic in vivo conditions may increase the efficacy of 
vaccines prepared from in vitro M. haemolytica cultures. 
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Preliminary results in our lab indicated that M. haemolytica might express an IgBP(s). 
When normal bovine serum (NBS) is used as a negative control to label whole cell M. 
haemolytica in an ELISA, similar absorbance values are obtained with the NBS and with an 
anti-sera specific for an M. haemolytica iron-regulated protein (L.B. Tabatabai, unpublished 
observations). The objectives of the present study were: 1) To identify and isolate an M. 
haemolytica IgBP(s); 2) To determine the presence or absence of IgBP surface expression; 3) 
To determine whether there is an increased antibody response to the IgP in cattle 
convalescing from BRD; 4) To determine whether the IgBP may play a role in the 
dominance of ST1 association with BRD (Wessman and Hilker, 1968 and Frank, 1979) or 
the dominance of ST2 in sheep mannheimiosis (Fraser, 1982); 5) To establish whether the 
IgBP binds one or more ECMPs; and 6) To assess whether this protein would be up-
regulated when grown under in vitro growth conditions that more closely mimic factors of 
the in vivo environment. 
Dissertation Organization 
This dissertation consists of four chapters. Chapter 1 is a general introduction and 
review of the literature on Mannheimia haemolytica, immunoglobulin-binding proteins and 
extracellular matrix-binding proteins. Chapter 2 and 3 consist of two papers. The first paper, 
"Identification, isolation and characterization of an immunoglobulin-binding protein 
expressed by Mannheimia haemolytica" is to be submitted for publication in the journal 
Infection and Immunity. The second paper, "Fibrinogen- and fibronectin-binding of a 
Mannheimia haemolytica immunoglobulin-binding protein differentially expressed in vitro," 
will also be submitted to Infection and Immunity. Chapter 4 consists of a general discussion 
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and conclusions. References for the general introduction and the literature review are in 
alphabetical order and follow the literature review. References for each paper follow the 
discussion section of each paper while the references for the general discussion and 
conclusion references follow that section. 
Literature Review 
Mannheimia haemolytica 
Taxonomy 
Whether Perroncito in 1878, Pasteur in 1880, or Kitt in 1885, was the first to isolate 
and describe the bacillus associated with fowl cholera is not clear. Bacilli with similar 
characteristics were associated with diseases of rabbits, swine and cattle and with fowl 
cholera. These diseases were characterized as being associated with hemorrhagic septicemia. 
Italian Count Trevisan first proposed the genus name Pasteurella (Holmes et al., 1999) for 
these organisms in honor of Pasteur's work on fowl cholera. After a series of name changes. 
Newsom and Cross (1932) proposed that organisms associated with bovine hemorrhagic 
septicemia and pneumonia be given the name Pasteurella haemolytica. Shirlaw (1938) 
termed the disease bovine pasteurellosis and Smith (1961) described two biotypes of P. 
haemolytica that he termed A and T. These letters stood for arabinose and trehalose 
fermentation, respectively. Seventeen serotypes (ST) have been defined (Biberstein et. al, 
1960; Fodor et al., 1988; Pegram et al., 1979; Younan, 1995), twelve associated with biotype 
A and four associated with biotype T. The T biotypes were reclassified into a new species 
Pasteurella trehalosi in 1990 and include serotypes 3, 4, 10 and 15 (Bingham et al., 1990). 
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Through DNA-DNA hybridizations and 16S rRNA sequencing, Angen proposed 
reclassifying Pasteurella haemolytica organisms into the new genus Mannheimia (Angen, 
1999). This now includes serotypes 1, 2, 5, 6, 7, 8, 9, 12, 13, 14, 16 and 17. Mannheimia 
belongs to the Pasteurellaceae family that consists of the genera Haemophilus, Actinobacillus 
and Pasteurella, the HAP organisms. 
Physical characteristics 
M. haemolytica are small, non-motile, pleomorphic, gram-negative, cocco-bacilli. 
The bacteria have a serotype specific capsular polysaccharide. Log phase cultures tend to be 
encapsulated while older cultures are generally not encapsulated (Corstvet et al., 1982). 
After multiple passages in vitro, M. haemolytica ST1 maintains capsular polysaccharide 
production (Gentry et al., 1987). There are no flagella on M. haemolytica but two types of 
fimbrae have been reported (Morck et al., 1987; Potter et al., 1988). When grown on ovine 
or bovine blood agar a narrow zone of ^-hemolysis is seen and smooth gray colonies are 
seen. 
Bovine respiratory disease 
Etiology and epidemiology. Because BRD is brought on by multiple factors, the 
etiology of BRD is not always clear. However, it is generally agreed that M. haemolytica 
ST1 is the primary causative agent of BRD or shipping fever (Frank, 1979 and Confer, 
1988). Serotype 1 is the predominant serotype isolated in BRD (Frank, 1979 and Frank et 
al., 1983) and is almost solely isolated from cattle that have died from BRD (Fox et al., 1971; 
Allan et al., 1985). 
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The incidence of BRD is associated with stress. Stress can be due to management 
practices such as shipping, weaning, crowding, comingling of herds, dehorning and 
castration. Viral infections are also considered to be predisposing factors in BRD. A study 
reveals that infectious bovine rhinotracheitis virus (IBR), bovine viral diarrhea virus (BVDV) 
parainfluenza type three virus (PI-3) and bovine bovine respiratory syncytial virus (BRSV) 
are associated with respiratory disease (Martin and Bohac, 1986). The greatest incidence of 
disease occurs in shipping yards and feedlots following shipment of animals; thus BRD is 
also called shipping fever. Dairy cattle are also known to have the disease. Serotype 2 is 
most frequently isolated from M. haemolytica-infected sheep (Fraser et al., 1982). 
Pathogenesis. M. haemolytica serotype (ST2) is a normal flora bacteria of the upper 
respiratory tract (URT) in cattle but on occurrence of a stressful incident such as viral 
infection or shipping from farm to feedlot, isolates of M. haemolytica shift from ST2 to ST1 
and can grow explosively colonizing the URT (Frank 1979; Frank and Smith, 1983; Jones, 
1987; Frank, 1988). The mechanism for the abrupt change from the predominance of the 
normal flora M. haemolytica ST2 to explosive growth of stress-associated ST1 is not known. 
However, change in host environmental factors due to stress is likely to play a role. 
The mechanism used by M. haemolytica to colonize the URT is also not clear. The 
bacteria may adhere to mucosal epithelial cells or proliferate within the mucous layer. 
Fimbrae have been reported in vitro on M. haemolytica (Morck et al., 1987, Potter et al., 
1988), but fimbrae are not found in M. haemolytica isolated from the lung or URT of cattle 
(Gonzalez et al., 1993). In addition, their role in attachment has not been demonstrated. A 
number of Gram-negative bacteria express adhesins that are distinct from fimbrae (Minion et 
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al., 1986; Mooi et al., 1992). Healthy or non-stressed cattle make use of the mucociliary 
ladder to clear bacteria from the URT. However, in humans, the mucociliary ladder is 
impaired in Gram-negative bacterial pneumonia (Pavia, 1987). Viral infections may kill 
ciliated epithelial cells or alter cell ciliary function. Neuraminidase, expressed by M. 
haemolytica ST1 (Frank and Tabatabai, 1981) decreases the viscosity of bovine respiratory 
mucus (Milligan et al., 1978). Decreased viscosity could inhibit the clearance of M. 
haemolytica. Beyond the aforementioned possibilities, M. haemolytica may multiply so 
rapidly that clearance mechanisms are overwhelmed. It is hypothesized that the large 
number of M. haemolytica in the URT is then inhaled into the lung in aerosolized droplets. 
In healthy cattle, macrophage activation initiates an inflammatory response and along 
with a humoral immune response, the bacteria are cleared. However, in immunologically 
compromised cattle, the immune response is ineffective at clearing the bacteria and the 
inflammatory response itself becomes part of the pathology. Activation of alveolar 
macrophages by bacterial lipopolysaccharide (LPS) and leukotoxin (Lkt) results in secretion 
of Interleukin-1 (IL-1), tumor necrosis factor alpha (TNFa) and Interleukin-8 (IL-8), 
proinflammatory cytokines (Yoo et al., 1995; Lafleur et al., 2001). Caswell (2001) 
demonstrated that IL-8 is an important neutrophil chemoattractant found in bronchoalveolar 
lavage (BAL) from calves with pneumonic pasteurellosis. After aerosol exposure of calves 
to M. haemolytica, lung lavage fluid contains an influx of neutrophils 30 minutes after 
exposure and by 60 minutes there is an equal percentage of alveolar macrophages and 
neutrophils. Four hours post-infection, more than 90% of cells are neutrophils (Walker et al., 
1985). In separate experiments macrophages from BAL fluid express IL-1, TNFa and IL-8 
within the first four hours after infection with IL-8 being expressed to the greatest extent. By 
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eight hours post-infection the neutrophils are the predominant source of IL-8 in BAL fluid 
(Malazdrewich et al., 2001). Neutrophils are stimulated by low concentrations of an M. 
haemolytica secreted Lkt to undergo a respiratory burst that results in the release of 
superoxide anion, hydrogen peroxide (Czuprynski et al., 1991) and lysosomal proteolytic 
enzymes (Styrt et al., 1990). The result of the release of oxygen products and proteases is 
tissue injury and necrosis. An indication of the central role neutrophil activation plays in 
lesion development is shown in experiments in which neutrophil depletion reduced lesion 
severity (Breider et al., 1988). The lipid A portion of LPS is known to be able to activate the 
classical complement pathway (Morrison and Rudback, 1981) while the polysaccharide 
component activates the alternate complement pathway (Morrison and Ulevitch, 1978). 
Products of complement activation contribute to the inflammatory response. 
Characteristic lesions of pneumonic mannheimiosis and associated lung damage are 
believed to occur as a result of host-pathogen interactions and an inflated inflammatory 
response. Typical lesions of shipping fever involve alveolar edema, hemorrhage, 
neutrophilic and fibrinous exudates and pulmonary vascular thrombosis. Inflammatory cells 
and fibrous tissue surround focal areas of coagulation necrosis. Within these lesions are 
characteristic "streaming macrophages" (Jubb et al., 1985). Experiments by Reeve-Johnson 
et al. (2001) noted higher clinical scores in calves with temperatures of 39.9 to 41,0°C 
compared to normal temperatures of 39.2°C. Death is thought to result from hypoxia or 
toxemia. 
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Virulence factors 
A number of virulence factors have been identified in M. haemolytica induced BRD. 
The role of some virulence factors is well studied while the mechanism of action of others 
remains to be determined. The role of several virulence factors are deduced from the role of 
similar virulence factors in other organisms. The most well characterized virulence factors 
are the leukotoxin and lipopolysaccharide. 
Leukotoxin (Lkt). In 1978, it was determined that M. haemolytica is cytotoxic for 
bovine leukocytes (Benson et al., 1978). Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) determined its molecular weight to be 101-105 kDa (Chang et 
al., 1987). Shewen and Wilkie (1982) showed that Lkt is specific for ruminant neutrophils, 
monocytes, macrophages and lymphocytes. It is produced during logarithmic phase but not 
in the stationery phase of growth (Shewen and Wilkie, 1985). In 1987 the gene was cloned 
and sequenced (Lo et al., 1987). Leukotoxin is a member of the RTX family of cytolysins 
that are pore-forming toxins (Whitely et al., 1992). Reports also demonstrate that the Lkt can 
apoptotically induce cell death (Wang et al., 1998). 
The activity of the Lkt is responsible for a great deal of the pathological effects of 
BRD. One group of researchers showed that subcytolytic concentrations of Lkt stimulate 
activation of neutrophils which results in a respiratory burst that releases superoxide anion 
and hydrogen peroxide. This is followed by degranulation and cytolysis (Maheswaran et al., 
1992). Release of these oxygen products and proteolytic enzymes would be expected to 
cause tissue necrosis. High concentrations of Lkt are lytic for ruminant leukocytes. More 
study is necessary to determine whether low or high concentrations of Lkt are more 
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detrimental to the host. Other activities of Lkt include stimulating the release of IL-1 and 
TNFa from macrophages (Yoo et al., 1995) and histamine from mast cells (Adusu et al., 
1994). These cytokines are known to contribute to increased capillary permeability, 
neutrophil influx and the inflammatory response associated with BRD. 
Lipopolysaccharide (LPS). M. haemolytica LPS induces a complex set of responses 
from a variety of cell types. Endotoxin from M. haemolytica LPS is released into the 
inflammatory exudate and is localized in neutrophils, macrophages, endothelial cells and 
epithelial cells (Whitely et al., 1990). The interaction of endotoxin and cells leads to cell 
activation or cell death. Some of the actions mediated by endotoxin include but are not 
limited to coagulation, inflammation and release of oxygen products. Lipopolysaccharide 
activated endothelial cells and macrophages produce a wide variety of proinflammatory and 
procoagulant mediators (Gartner et al., 1988; Cotran, 1987; Russo, 1980; Tipping et al., 
1988). Alveolar macrophages produce toxic oxygen radicals and proteases as well as nitric 
oxide in response to M. haemolytica LPS. (Werb, 1983; Dyer et al., 1985; Yoo et al., 1996). 
Interestingly, Lafleur et al. (2001) reported a synergistic response between LPS and Lkt in 
inducing cytolysis and inflammatory cytokine (TNFa and IL-8) production in bovine 
alveolar macrophages. LPS primes neutrophils for release of toxic oxygen products and 
lysosomal enzymes. Even though LPS effects are multifaceted, antibodies to LPS are not 
associated with protection (Confer et al., 1988). 
Capsular polysaccharide (CPS). The M. haemolytica CPS has been shown to 
augment the ability of the bacteria to resist phagocytosis and can hinder complement-
mediated lysis (Confer et al., 1990b; Czuprynski et al., 1991). However, recent construction 
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of an acapsular mutant demonstrates that the mutant is as resistant to complement-mediated 
killing in colostrum-deprived calf serum as the encapsulated parent strain. Nonetheless, it is 
more sensitve to killing by immune bovine serum (McKerral and Lo, 2002). Barallo et al. 
(1999) observed that production of the CPS in ST2 is strictly temperature regulated and that 
no production is detected above 40°C. 
O-sialoglycoprotease. In 1992, Abdullah recognized that M. haemolytica produces a 
35-kDa O-sialoglycoprotease found in the culture supernatant that cleaves O-glycosylated 
proteins but not N-glycosylated proteins. Antibodies to this enzyme are found in bovine sera 
(Lee et al., 1994). Tabatabai (1981) observed that fetuin is a substrate for the M. haemolytica 
O-sialoglycoprotease and can be used as an alternative substrate to identify the protease 
activity. M. haemolytica O-sialoglycoprotease enhances bovine platelet adhesion which 
would indicate a role in thrombosis during mannheimiosis (Nyarko et al., 1998). 
Neuraminidase. Neuraminidase is implicated as a virulence factor in bacteria. 
When sialic acid residues are removed from salivary glycoproteins, salivary secretions are 
less able to protect against pathogenic bacteria (Gottschalk, 1960). This would enhance the 
ability of microorganisms to survive in vivo. Neuraminidase production was first 
demonstrated in M. haemolytica by Scharmann et al. (1970). Frank and Tabatabai (1981) 
characterized the production of neuraminidase by different M. haemolytica serotypes and 
isolates. They also reported that antiserum to M. haemolytica is capable of neutralizing 
neuraminidase activity. Straus and Purdy (1995) established that neuraminidase is produced 
in vivo in market stressed cattle. 
Fimbrae. In order for rapidly multiplying M. haemolytica to colonize the 
nasopharynx the bacteria must either adhere to mucosal epithelial cells or proliferate within 
the mucous layer. Fimbrae are associated with epithelial cell adherence in a number of 
bacteria and Potter et al. (1988) and Morck et al. (1987) reported M. haemolytica associated 
fimbrae. Two types of fimbrae, a large, rigid fimbrae (Morck et al., 1987) as well a smaller, 
flexible fimbrae (Potter et al., 1988) have been reported but fimbrae have are not found in M. 
haemolytica isolated from the lung or URT of cattle (Gonzalez et al., 1993). In addition, 
their role in attachment has not been demonstrated. A number of Gram-negative bacteria 
express adhesins that are distinct from fimbrae (Minion et al., 1986; Mooi et al., 1992). It is 
possible that an unknown virulence factor or other known virulence factors such as 
neuraminidase play a role in adherence so that the involvement of fimbrae may not be 
essential for colonization. 
Iron-regulated proteins. The host sequesters iron during infection whereas 
organisms up-regulate the expression of iron-regulated proteins for iron-uptake when the 
organism is in an iron-restricted environment such as the lung (Donachie and Gilmour, 1988; 
Confer et al., 1995). Iron is essential in a variety of cellular functions for both the host and 
an invading organism. M. haemolytica expresses iron-regulated proteins, both outer 
membrane proteins (Donachie and Gilmour, 1988; Lainson et al., 1991; Confer et al., 1995) 
termed transferrin binding protein A and B (TbpA and TbpB) and periplasmic proteins 
(Lainson et al.,1991; Tabatabai and Frank, 1997) termed ferric binding protein A and B 
(FbpA and FbpB). TbpA and TbpB are receptors for transferring iron (Ogunnariwo and 
Schryvers, 1990; Gray-Owen, 1996) while FbpA and FbpB function as iron-binding and 
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iron-transport proteins (Gray-Owen and Schryvers, 1996; Kirby et al., 1998). Davies et al. 
(1992) showed that expression of outer membrane iron-regulated proteins increases when M. 
haemolytica are grown under iron-restricted conditions and that this increase occurrs only in 
disease-associated strains. Belzer et al. (2000) reported that convalescent calves have high 
antibody titers to the 35 kDa FbpA. The native FbpA does not cross-react with other 
Pasteurella trehalosi serovars (Tabatabai and Frank 1997). 
Vaccines 
An ideal vaccine would provide long-term protection against disease, be easily 
administered and have no adverse reactions. A significant degree of protection from 
pneumonic mannheimiosis is achieved through passive transfer of humoral immunity 
(Mosier et al., 1995) and calves challenged with M. haemolytica after an experimental 
infection shows no clinical signs of disease (Cho and Jericho, 1986). These results indicate 
that protection from an M. haemolytica challenge is possible. However, the history of 
vaccine development for M. haemolytica-induced BRD has shown that this is not an easy 
task and full protection for all animals may never be achieved. Although a number of 
important virulence factors are identified, none of them alone has been sufficient to provide 
protection. A variety of vaccine formulations have been tested including bacterins, live 
vaccines and subunit vaccines. Protection is variable. Often there is a significant difference 
in the efficacy of a particular vaccine between experimental trials and field trials and 
repetition of results from individual trials has been inconsistent. Experimental trials are 
hampered by a lack of a suitable laboratory animal model of BRD. Trials are limited by 
animal size and availability of accommodations keeping many trials to a small number of 
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animals. More knowledge about the pathogenesis of pneumonic mannheimiosis may be 
necessary for development of a consistently effective vaccine. 
History. Early vaccine effectiveness was limited due to confusion over which 
organisms to incorporate into a vaccine. Vaccines included M. haemolytica and P. multocida 
as well as the viruses infectious bovine rhinotracheitis (IBR) and parainfluenza-3 (Pl-3) 
individually and in various combinations. M. haemolytica alone was shown to produce 
fibrinous pneumonia which reduced the focus on bacterial vaccines to M. haemolytica 
(Confer et al., 1989). Because virally induced stress is associated with BRD, viral vaccine 
formulations remain an area of experimentation. Initial vaccines consisted of bacterins, viral 
vaccines or bacterin-viral combinations. None of these provided consistent protection. In 
the 1980s live vaccines at times were successful although at times no effect due to 
vaccination was found (Purdy, et al., 1986). More recently, efforts have been focused on 
subunit vaccines incorporating known virulence factors and bacterial cell extracts. 
Bacterins. Bacterin vaccines in different trials are shown to be somewhat protective 
(Mosier, 1989), have no effect (Confer et al., 1985b) or at other times result in more severe 
lesions (Friend et al., 1977; Wilkie et al., 1980). Confer et al. (1985) showed that while no 
effect is found with a bacterin vaccine, a live vaccine in that same trial results in significant 
reduction in pulmonary lesions. The focus for vaccine production shifted to live vaccines. 
Live vaccines. During the 1980s, the protective effect of live and modified-live 
vaccines was explored. In an experimental transthoracic challenge of calves following 
vaccination with either a bacterin or a live M. haemolytica vaccine, little reduction in mean 
lesion scores resulted from a formalin-killed bacterin vaccination (Confer et al., 1985). 
However, a live M. haemolytica vaccine grown on brain-heart infusion agar results in at least 
a four-fold reduction in lesion scores when compared to control animals. Although nearly 
60% of the bacterin-treated calves had antibody titers that were as high or higher than live-
vaccinates, no correlation is found between these antibody titers and resistance to infection. 
A similar effect was seen in experiments by Panciera et al. (1984). However, Purdy et al. 
(1986) found no significant effect on performance, morbidity or mortality from a live, freeze-
dried vaccine in field trial conditions. A modified-live lyophilized M. haemolytica vaccine 
trial resulted in greater than a two-fold reduction in lesion scores (Blanchard et al., 1987). 
The reduction in protection afforded by modified-live vaccines compared to live vaccines 
may be due to the loss of antigens important for protection or the presence of replicating M 
haemolytica may be necessary. The effectiveness of live vaccines is limited by the 
concurrent administration of antibiotics and is sensitive to improper storage and 
administration of the vaccine preparations. 
Subunit vaccines. More recent vaccination efforts have focused on subunit vaccines. 
High antibody titers to various antigens of M. haemolytica correlate with protection. High 
antibody responses to both the leukotoxin and the CPS correlate with protection in cattle 
(Confer et al., 1985a). As more is learned about the pathogenesis of pneumonic 
mannheimiosis and the role of different virulence factors, it is anticipated that vaccines 
incorporating or enriched in known virulence factors will provide better protection. 
Presponse is a commercial vaccine incorporating an enriched leukotoxin fraction with 
culture supernatant. The culture supernatant contains ST1 specific antigens and other soluble 
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capsular material. A number of experiments involving Presponse show an approximately 
two fold increase in protection following Presponse vaccination (Shewen and Wilkie, 1989; 
Shewen et. al., 1988; Jim et. al., 1988). In one experimental trial, a vaccine incorporating 
Presponse enriched with recombinant Lkt is more efficacious than Presponse alone (Conlon 
et al., 1991). 
A vaccine composed of outer membrane proteins of M. haemolytica with no 
leukotoxin resulted in lesion scores similar to scores found with live vaccinates (Morton, et 
al., 1995). This argues against the importance of Lkt in vaccine formulations. Gilmour et al. 
(1991) and Potter et al. (1999) demonstrated the importance of iron-regulated proteins in 
protection. Incorporation of iron-regulated proteins in a sodium salicylate extract vaccine in 
sheep results in almost complete protection (Gilmour, 1991). Vaccination with iron-
regulated proteins TbpA and TbpB alone resulted in a fourfold decrease in clinical scores 
compared to unvaccinated calves (Potter et al., 1999). There is also experimental evidence 
for a role for the CPS in protection of goats (Purdy et al., 1993). Vaccines containing M. 
haemolytica chemical extracts show some promise for protection. A recent experiment 
involving an M. haemolytica sodium salicylate extract enriched with LPS, Lkt, iron-regulated 
outer membrane proteins and CPS resulted in mean clinical lesion scores similar to that 
found with live vaccines (Sreevatsan et al., 1996). Subunit vaccines avoid the inherent 
problems a live vaccine presents and appear to hold promise in deriving an effective vaccine. 
Growth condition dependent protein expression. Pathogenic bacteria may express 
different components when grown in vivo rather than in vitro (Davies et al., 1994). In an 
effort to recreate in vivo protein expression while using in vitro systems and also to define 
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culture conditions that affect expression of particular proteins, a number of studies have been 
done to define protein expression under different culture conditions. Conventional media for 
in vitro growth is usually selected for its ability to support M. haemolytica growth. Shewen 
and Wilkie (1982) reported that the addition of 7% fetal bovine serum (FBS) to RPMI-1640 
tissue culture media achieves enhanced M. haemolytica leukotoxin production compared to 
tissue culture media alone. This may be due to the presence of iron in FBS, because Gentry 
et al. (1986) demonstrated that the addition of iron compounds to culture media results in 
leukotoxin production levels comparable to FBS induced leukotoxin production levels. Iron-
regulated outer membrane proteins of 71, 77 and 100 kDa are expressed at higher levels in 
iron-restricted media (Deneer et al., 1989; Morck, 1991). Increased expression levels of 
outer membrane proteins (OMPs) are found in M. haemolytica grown in decomplemented 
fetal calf serum (Davies et al., 1992). 
In another study, M. haemolytica OMP protein expression was compared between 
bacteria that were isolated from lungs of experimentally infected calves to bacteria cultured 
under various in vitro growth conditions. OMP expression profiles on SDS-PAGE are 
similar for M. haemolytica isolated from lungs and M. haemolytica grown in newborn calf 
serum (Davies et al., 1994). No CPS production is detected when M. haemolytica is grown 
above 40°C. When M. haemolytica is grown at 43°C, enzymes involved in CPS biosynthesis 
are found at a level at least 25 times lower than M. haemolytica grown at 37°C (Barallo, 
1999). Establishing in vitro growth conditions that closely mimic in vivo conditions may 
increase the efficacy of vaccines prepared from in vitro M. haemolytica cultures. 
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Immunoglobulin-binding proteins (IgBPs) 
Immunoglobulin-binding proteins are expressed by a number of bacteria and bind 
immunoglobulins non-specifically, typically on the Fc or Fab portion of the molecule. They 
are believed to be virulence factors. 
History. The phenomenon of bacterial surface proteins binding to immunoglobulins 
in a nonspecific manner was described well before the basis for this reactivity was 
understood. Jensen (1958) demonstrated reactivity between Staphylococcus aureus and 500 
normal human serum samples. This reactivity does not correlate with previous known 
exposure to the bacteria. He termed this a kind of natural immunity or pseudoimmune 
reactivity and called the bacterial surface antigen involved antigen A. In another 
demonstration of antigen A reactivity, Cohen et al. (1961) found S. aureus binds rabbit sera 
with no known previous exposure to the bacteria. Antigen A was termed protein A after its 
protein nature was determined by digestion with trypsin (Grov et al., 1964). Sjôquist 
combined new found biochemical knowledge of immunoglobulins with work to define the 
antigens on the surface of S. aureus and along with Fôrsgren determined protein A binds to 
the Fc portion of IgG (Fôrsgren and Sjôquist, 1966). In their research, gel filtration purified 
protein A and papain digested IgG Fc fragments precipitated in an agar gel Ouchterlony 
plate. Until recently, bacterial proteins that bind immunoglobulins were termed Fc receptors. 
More recently, they have been termed immunoglobulin-binding proteins (IgBPs) in 
recognition of the fact that they have no signaling capability as other cell surface receptors 
have. 
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Protein A. Further characterization of protein A showed that it is a cell surface 
protein (Sjôquist et al., 1972) with a molecular weight of 42-kDa and has a distinct extended 
shape (Bjorck et al., 1972). Protein A is antiphagocytic and chemotactic in vitro (Dosset et 
al., 1969), and IgG complexed with protein A activates complement via the classical pathway 
(Sjôquist and Stâlenheim, 1969). The discovery of extracellular protein A in methicillin-
resistant S. aureus (Lindmark et al., 1977) led to the development of a method for 
purification and production of soluble protein A. Work focused towards the widespread 
utilization of protein A as an immunochemical regent in detecting and isolating antibodies 
and little attention was paid to its role in S. aureus infections. 
Immunoglobulin-binding protein classification. An IgBP was discovered on the 
surface of ^-hemolytic streptococci. This protein is called protein G and it is a cell surface 
expressed and secreted IgBP associated with groups A, C, and G streptococci (Kronvall. 
1973). Protein G, like Protein A, is an elongated molecule (Âkerstrom and Bjorck. 1986). 
The discovery of protein G led to the concept that proteins on the surface of bacteria that 
nonspecifically bind immunoglobulins may be a general feature of bacteria-host interactions. 
Following this finding a systematic study determined that many Gram-positive bacteria 
express IgBPs that bind Ig from a variety of Ig sources. Myhre and Kronvall (1977, 1980, 
1981), and Myhre et al. (1979) described five different types of IgBPs based on functional 
binding properties of bacteria to Igs from different species and antigenic relatedness. In 
1988, Reiss identified a sixth type of IgBP based on these same criteria (Reiss, 1990). 
Immunoglobulin binding proteins have been identified on other Gram-positive as well 
as Gram-negative bacteria. Coprococcus comes (Van de Merwe and Stegeman, 1985), 
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Haemophilus somnus (Widder et al., 1988), Brucella abortus (Bricker et al., 1991), 
Actinobacillus actinomycetemcomitans (Mintz et al., 1994), Aeromonas salmonicida (Phipps 
and Kay, 1988) and Escherichia coli (Sandt et al., 1997) are all known to express IgBPs. No 
published information is available that describes classification of IgBPs from gram-negative 
organisms. 
Immunoglobulin-binding protein specificity. IgBPs bind immunoglobulins other 
than Fc IgG. Protein L from Peptostreptococcus magnus binds k light chains (Bjorck, 1988) 
and protein A and protein G bind Fab and F(ab')a respectively (Boyle, 2000). Clostridium 
perfringes expresses an IgBP termed protein P that also binds F(ab')2 fragments (Boyle, 
2000). Neisseria catarrhalis, group A, C and G streptococci, Haemophilus influenzae 
(Forsgren and Grubb, 1979), Haemophilus haemolyticus and Haemophilus aegypticus 
(Akkoyunlu, 1991) all bind human IgD. M proteins sir (Stenberg, 1994) and arp (Heden and 
Lindahl, 1993) and a specific IgA receptor on group B streptococci (Lindahl, 1990) bind 
human IgA. Protein sir also binds IgM. Additional specificity for IgM has been reported for 
B. abortus (Nielsen, et al., 1981), and Borrelia burgdorfori (Dorward, et al., 1992). 
Immunoglobulins are not the only proteins IgBPs bind. While it has been known 
since 1987 that protein G binds albumin and IgG (Bjorck, 1987), more recent work has 
shown that other IgBPs bind other proteins. Specificity for binding plasminogen (Berge and 
Sjôbring, 1993), C4-binding protein (Thern, 1995) fibrinogen and fibronectin (Reichardt, et 
al., 1995) and factor H (Kotarsky, 1998) has been demonstrated. Protien G has separate 
binding sites for IgG and albumin (Frick et al., 1994, 1995). The Fc binding portions of 
protein G bind two plasma proteinase inhibitors, alpha-2 macroglobulin and kininogen. 
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Binding for all three proteins apparently occurs within the IgG binding domains (Bjorck et 
al., 1987; Sjôbring et al., 1989) 
Immunoglobulin-binding proteins and virulence. Fc-mediated antibody binding to 
the surface of IgBP expressing bacteria has provided the classical picture for a role for IgBPs 
in virulence. Antibody bound to the surface of bacteria would provide a means for bacteria 
to evade the host immune response by inhibiting phagocytosis and complement-mediated 
killing. Additionally, soluble IgBPs bound to antibodies would decrease the number of 
specific antibodies available for a humoral immune response. While these effects have been 
demonstrated in vitro, the role of IgBPs in virulence in vivo has been more difficult to 
demonstrate. But this does not preclude a role for IgBPs in virulence. Continuing research 
shows a greater IgBP role in virulence than had originally been conceived. 
Superantigens. In 1979, it was established that protein A bound Fab IgG and 
that this binding took place outside the antigen-binding site (Endressen, 1979). Protein A 
binds the Fab portion of IgA, IgM and IgE (Inganas, 1981). Protein A binding is restricted to 
antibodies coded by the VH3 family of genes (Sasso, et al., 1991) and 32-54% of all 
circulating B cells are capable of this binding. Protein A is also capable of binding 
membrane bound immunoglobulins. This binding is similar to that found with T cell 
superantigens. 
Protein A, acting as a B cell superantigen, activates complement (Kozlowski et al., 
1996), induces expression of Ig from the Vh3 gene family (Kristiansen et al., 1994), 
increases antigen presentation through soluble protein A:Ig complexes associated with Vh3 
family surfaced expressed immunoglobulins (Leonetti et al., 1999) and soluble protein A:Ig 
L 
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complexes are involved in inflammation as demonstrated by the elicitation of an Arthus 
reaction (Kozlowski et al., 1998). Protein A and protein L, acting as superantigens, activate 
human heart mast cells by binding IgE on the surface of cells (Genovese, 2000). 
Although these responses may appear to have a strong role in virulence, recently a 
perhaps more far reaching role has been found for protein A acting as a superantigen via 
suppression of Vh3 expressing B cells. Following intraperitoneal immunization of both 
neonatal and adult VH3 "knock in" mice with protein A, researchers demonstrated a selective 
suppression in Vh3 expressing IgM secreting cells in both the spleen and liver and a loss of 
detectable Vh3 expressing B-l lymphocytes in the peritoneum. This suppression is T cell 
independent and selectively suppresses a set of Vh3 antigen-specific natural antibodies. Mice 
treated with protein A are tolerant to a whole cell S. pneumonia extract as measured by 
ELISPOT assay for specific IgM secreting cells. After cessation of protein A treatment, 
splenic lymphocytes (B-2 B cells) return to normal whereas the suppression of peritoneal 
lymphocytes (B-l B cells) is still present 7-21 weeks later (Silverman et al., 2000). This 
study demonstrates a potentially very important role for IgBP involvement in virulence. 
Mitogens. Protein A activates lymphocyte proliferation. This activation is 
limited to B cells with no T cell stimulation found. Optimal stimulation results when protein 
A is immobilized either on Sepharose or on the surface of S. aureus (Fôrsgren, et al., 1976). 
Stimulation occurrs with IgG, IgD and IgM bearing B cells (Romagnani, et al., 1980). 
Mitogenic activity of Protein A persists when tyrosil residues necessary for Fc IgG binding 
were inactivated and appeared to be due to Fab binding (Romagnani, et al., 1982). 
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Complement activation and inhibition. Early studies demonstrated that 
soluble protein A:IgG complexes fixes complement (Sjôquist and Stâlenheim, 1969). 
Langone et al (1978) showed that protein A and IgG complexes in the molecular formula 
[(IgG): protein A]2 act like IgM molecules in fixing complement and lysing erythrocytes. 
More recently, protein H was shown to form soluble complement-activating complexes that 
cleave C3 but to inhibit complement activation by Ig-coated target. Protein H inhibits Clq 
binding to IgG immobilized on polyacrylamide beads (Berge, 1997). 
Antiphagocytes. In 1969, Dosset et al. showed that protein A on the surface 
of S. aureus inhibits phagocytosis and that this effect is dose dependent. This phenomenon 
has been demonstrated with a number of IgBPs and more recently was shown with protein H 
from Streptococcus pyogenes (Kihlberg et al., 1999). 
Antibody-dependent cellular cytotoxicity inhibition. IgBPs have been 
shown to inhibit antibody-dependent cellular cytotoxicity. Rosenblatt (1977) showed that 
incubation of antibody-coated target cells with protein A inhibits lysis by lymphocytes. 
Virulence role in vivo. The association of disease and IgBP expression has 
been difficult to show in vivo. This may be because of the complex nature of virulence and 
because even though an IgBP may have been identified in an organism, it may not be the 
only IgBP expressed by that organism. This was demonstrated in a protein A deficient 
mutant S. aureus infection. The mutants were constructed with site-directed allelic 
replacement. The protein A-deficient mutants are marginally less virulent than protein A 
expressing S. aureus as measured by death after intraperitoneal injections of bacteria in mice. 
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The mice injected with protein A expressing S. aureus die significantly more quickly than 
mice injected with the mutant (Patel et al., 1987). The mechanism for the reduction in 
virulence is not known and the results may have been more dramatic if a second IgBP S. 
aureus has recently been shown to express, Sbi, (Zhang, 1998) had also been deleted. 
Further evidence for IgBPs role in virulence was established in H. somnus infection in cattle. 
Pathogenic and carrier isolates were checked for immunoglobulin-Fc binding activity. All 
isolates express binding activity except for carrier isolates from the prepuce of bulls. None 
of these binds IgG-Fc (Widders, 1989). Finally, the immunoglobulin-binding domains of 
protein L form P. magnus, a pathogenic vaginal colonizer, were expressed in Streptococcus 
godonii, an oral commensal. The recombinant bacteria show increased murine vaginal 
colonization and persisted for a longer time in the murine vagina (Ricci et al., 2001). These 
experiments show a role for IgBPs in bacterial virulence. 
Therapeutic uses of immunoglobulin-binding proteins (IgBPs). IgBPs fused to 
antigens increase immunogenicity. This was seen as an increased humoral immune response 
in vivo (Lowenadler et al., 1990) and in vitro as increased T cell presentation by antigen 
presenting cells expressing immunoglobulins on their surface (Leonetti, et al., 1998). Protein 
A has five Fc IgG binding sites (Hjelm et al., 1975 and Lôfdahl et al., 1983) and increased 
immunogenicity correlates with an increased number of immunoglobulin-binding sites on 
protein A fused to antigen (Leonetti, et al., 1998). These phenomena may prove important 
because it increases immunogenicity without an adjuvant. 
Protein A also has a number of biomodulatory effects. Protein A acts as a mitogen or 
induces apoptosis in the same cell depending on concentration. At a particular dose level, it 
28 
each with a molecular weight between 235-270 kDa. Each subunit is made up largely of 
three types of repeating modules, types I, II and III. A variable number of type III repeats 
contributes to the variability in subunit molecular weight. Fibronectin is a flexible, extended 
molecule. Fibronectin binds to cell surfaces and dimers polymerize to form fibrils. Cell 
adhesion is mediated by an arg-gly-glu (RGD) sequence of fibronectin that binds (3, 
integrins. With continued polymerization, Fn fibrils extend into the ECM. Matrix formation 
is a cooperative process involving interactions between Fn and other ECM components such 
as collagens, laminin and proteoglycans. Addition of heparin and collagen to cultures has 
been shown to increase Fn binding to cells (McKeown-Longo and Mosher, 1985). 
Transforming growth factor-(3 enhances expression of Fn matrix assembly sites and this is 
accompanied by an accumulation of Fn fibrils (Allen-Hoffman et al., 1998). Fibronectin also 
contains binding domains for fibrin, heparin, and collagen. 
Fibrinogen. Fibrinogen is a 340 kDa glycoprotein synthesized in 
hepatocytes. It is composed of three pairs of nonidentical chains that are linked by interchain 
disulfide bonds to form an Fg molecule. Fibrinogen is cleaved by thrombin to form fibrin 
and thus is involved in clotting. Fibrinogen also binds to a platelet receptor and mediates 
platelet adhesion and aggregation. Fibrinogen interacts with integrin receptors on endothelial 
cells (Cheresh, et al., 1989) and leukocytes (Altieri et al., 1990). 
Extracellular matrix-binding proteins 
Identification. Kuusela (1978) first reported that fibronectin would bind to S. 
aureus. Following this, two S. aureus Fn-binding proteins (FnBPs), FnbpA and FnbpB, were 
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identified (Signas et al., 1989 and Jônsson et al., 1991). FnbpA is known to bind Fg as well 
as Fn. (Wann et al., 2000). ECMBPs of S. aureus are best characterized and along with 
FnbpA and FnbpB include surface expressed type II collagen-binding protein (CnBP), 
clumping factor A and B (ClfA and ClfB), Fg-binding proteins, and a secreted Fg-binding 
protein (Efb) (in Flock review, 1999). One S. aureus ECMBP, extracellular adherence 
protein (Eap), binds seven plasma proteins including Fn and Fg (Palma et al., 1999). 
Although S. aureus ECMBPs are the best characterized, a sizeable number of other 
organisms express ECMBPs. Streptococcus spp. express ECMBPs. In addition, a number of 
Gram-negative organisms including Escherichia coli (Westerland et al., 1989), Haemophilus 
ducreyi (Abeck et al., 1992), H. influenza (Fink et al., 2002), Neisseria gonorrhoaea (van 
Putten et al., 1998), and Borellia burgdorferi (Probert and Johnson, 1998) express ECMBPs. 
Recently, ECMBP research has increased as their role in virulence is becoming more 
apparent. 
A number of IgBPs are known to also bind ECMPs. For example, Protein H, present 
in some strains of S. pyogenes and first known to bind Fc IgG, also binds fibronectin. A 
fibronectin binding protein also from S. pyogenes, Sfbl, binds Fc IgG (Frick et al, 1995; 
Medina et al, 1999). A Group C streptococci expresses protein F AI which binds fibrinogen, 
albumin and IgG (Talay et al 1996). In addition, FgBP, a fibrinogen-binding protein of 
Streptococcus equi, has recently been shown to bind equine Fc IgG (Meehan et al, 2001). 
Virulence association. Unlike IgBPs which were originally valued as reagents to 
isolate immunoglobulins, studies on extracellular matrix-binding proteins were focused on 
their role in virulence soon after these protein were identified. Although the mechanisms are 
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generally unclear, a number of roles for ECMBPs in virulence have been determined. 
Fibronectin-binding proteins in particular have been associated with virulence and once 
again, most work has been done with S. aureus. 
Exogenous Fn is required for internalization of S. aureus by HEp-2 cells. HEp-2 cells 
are unable to produce Fn. In this same study, monoclonal antibody to (3, integrins 
significantly reduced invasion which suggests a bridge is formed by Fn between an FnBP and 
Pi integrins (Dziewanowska et al., 2000). Recent work by Dziewanowska (2002) 
demonstrated that invasion into human corneal epithelial cells isreduced by 99% with an 
FnBP-deficient isogenic strain of S. aureus. Clearly, FnBPs play a role in S. aureus 
internalization. 
In relation to respiratory diseases, two sets of experiments illustrate the importance of 
S. aureus FnBPs in bacterial adherence to human endothelial and airway epithelial cells. 
Mongodin et al. (2002) established that an FnBP-deficient strain of S. aureus have a five-fold 
decrease in the level of adherence to human airway epithelial cells suggesting that FnBPs are 
involved in adherence. In 1999, Peacock et al., using a number of strains deficient in 
individual ECMBPss or protein A showed that only the mutant deficient in FnbpA and B 
production lowered adherence to endothelial cells. They conclude that their results indicate 
that Fnbp binding to endothelial cell Fn is the dominant pathway for S. aureus adherence to 
human endothelial cells in vitro. Bacterial cell adherence to host cells is a required initial 
step in most bacterial infections and ECMBPs, particularly FnBPs, may play a large role in 
this process or may be required for infection. 
In vivo and in vitro models demonstrate several additional roles for ECMBPs in 
virulence. Both FnBP and ClfA, a fibrinogen-binding protein, enhance S. aureus binding to 
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atopic skin as was found with S. aureus strains that did not produce one or the other of these 
proteins (Cho et al., 2001a). On human T cells, integrins ot4pi and otspi bind fibronectin and 
function as a costimulatory molecule for T cell activation. Miyamoto et al. (2001) 
established that S. aureus FnbpA through the T cell a$Pi integrin mediates adhesion to T 
cells and T cell activation in vitro in the presence of Fn and an anti-CD3 monoclonal 
antibody. In relation to this, S. aureus preferentially binds to skin sites of T helpers-
mediated sites of inflammation when compared to T helper-1 -mediated sites of inflammation 
in a murine model. Fibrinogen and Fn mediate this binding (Cho et al., 2001b). An isogenic 
mutant unable to produce the Fn- and Fg-binding protein of Streptococcus suis ST2 
decreases colonization of the joints and CNS of piglets while colonization of the tonsils is 
unaffected (de Greeff et al., 2002). The role of ECMBPs is not limited to adherence. 
Vaccine potential. In 1999, Brennan et al. demonstrated that antibodies raised to one 
of three fibronectin-binding sites on S. aureus Fnbp are able to block adherence of S. aureus 
to Fn in vitro. Work previous to this showed that antibodies to Fnbp opsonize S. aureus as 
seen in an in vitro phagocytosis assay. Also, mice clear opsonized bacteria from the 
peritoneal cavity and liver more rapidly than controls (Rozalska and Wadstrom, 1993). 
Mamo et al. (1995) described a 1000 fold reduction in the number of opsonized S. aureus 
recovered from mammary glands of mice injected with opsonized bacteria as well as a 
significant reduction in pathology. Mamo et al. (1994) showed that mice vaccinated with an 
Fn-binding domain from S. aureus Fnbp have a decreased number of bacteria recovered from 
mammary glands as well as a significantly reduced incidence of severe mastitis. In an 
organism other than S. aureus, immunization with Streptococcus pyogenes fibronectin-
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binding protein, FB54, results in mice that survive significantly longer than control mice. In 
the same study, an increased IgG titer to FB54 is increased in actively infected human 
patients compared to healthy volunteers (Kawabata et al., 2001). Hap is a broad-spectrum H. 
influenza expressed ECMBP that binds fibronectin, laminin and collagen IV. Cutter, et al. 
(2002) demonstrated that mice immunized intranasally with purified Hap significantly 
reducted the density of nasopharyngeal colonization compared to controls challenged with a 
heterologous strain of H. influenza. The overall results from the above-mentioned studies 
suggest that a vaccine-induced immune response to ECMBPs may reduce the incidence of 
disease. 
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CHAPTER 2. IDENTIFICATION, ISOLATION, AND CHARACTERIZATION OF 
AN IMMUNOGLOBULIN-BINDING PROTEIN EXPRESSED BY MANNHEIMIA 
HAEMOLYTICA 
Ruth Smith Osmundson and Louisa B. Tabatabai 
A paper to be submitted to Infection and Immunity 
Abstract 
Mannheimia haemolytica is the primary causative agent of bovine respiratory disease 
(BRD) or "shipping fever". Bacterial immunoglobulin-binding protein (IgBP) expression is 
known to play a role in the pathogenesis of a variety of organisms. This study demonstrated 
the presence of an IgBP in whole cell sonicates (WCSs) and a culture supernatant (CS) 
preparation from M. haemolytica serotype (ST) 1. Far-Western blot demonstrated binding of 
bovine Fc IgG to M. haemolytica expressed IgBP. An M. haemolytica IgBP(s) protein was 
isolated by affinity chromatography using bovine gamma globulin linked to Sepharose and 
flow cytometry showed the surface expression of an IgBP on whole cell M. haemolytica. 
Immune sera from convalescent cattle showed an increased antibody response to the 75.0 
kDa IgBP when compared to sera from naïve or acutely infected cattle as seen by Western 
blot. These results demonstrated the presence of an IgBP on the surface of M. haemolytica 
and that an immune response to the 75.0 kDa IgBP may play a role in protection from M. 
haemolytica infection. It was demonstrated that all 12 serotypes (1,2, 5-9, 12-14, and 16) 
bound both bovine Fc IgG and sheep Fc IgG without appreciable differences between ST1, 
most frequently isolated in infections in cattle and ST2, isolated predominantly in sheep 
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mannheimiosis. Serotype-specific Fc IgG binding did not appear to play a role in species-
specific infection by IgBPs from different serotypes of M. haemolytica. 
Introduction 
Bovine respiratory disease (BRD) or "shipping fever" is believed to result in the 
single largest loss annually to the cattle industry. BRD has a complex etiology but 
pulmonary fibrinous pneumonia, the ultimate cause of severe clinical disease and death, is 
primarily caused by Mannheimia haemolytica (20). Calves are chiefly affected and are 
predisposed to M.haemolytica infection following stressful incidents such as shipping, 
weaning or viral infection. M. haemolytica, a normal flora bacterium of the nasopharynx, 
increases in number and colonizes the upper respiratory tract following a stressful incident. 
The increased number of M. haemolytica are believed to be inhaled into the lung resulting in 
macrophage activation and pulmonary serum flooding. An influx of neutrophils along with 
an M. haemolytica secreted leukotoxin exacerbates the response. This leads to lung lesions 
characteristic of M. haemolytica-'mduced fibrinohemorrhagic pneumonia. Some animals are 
able to recover while others succumb to pneumonic mannheimiosis (45). 
A number of vaccines are available for M. haemolytica induced BRD. Bacterins 
provide protection of variable efficacy. A number of experimental trials even show an 
exacerbation of BRD in bacterin vaccinates (17,47). While live vaccines generally perform 
better in field-tests than bacterins (7), live vaccines still have variable efficacy with some 
trials showing no increase in protection due to immunization (35). Also, live vaccines have 
inherent problems with production and stability. While not providing full protection, 
bacterial component vaccines demonstrate the importance of leukotoxin (8), iron binding 
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proteins (34) and surface antigens (39) in protection. There is a need for a more efficacious 
vaccine. 
M. haemolytica expresses a number of known virulence factors. The best 
characterized is a leukotoxin (21), a member of the RTX toxin family. While the leukotoxin 
is a major virulence factor, immunization with the leukotoxin alone is not sufficient to 
provide protection (43). Other virulence factors include the capsular polysaccharide (5), LPS 
(36), fimbrae (31), iron-regulated proteins, (9), neuraminidase (13) and O-sialoglycoprotease 
(1). This study demonstrated the presence of an additional M. haemolytica virulence factor, 
an immunoglobulin-binding protein (IgBP). 
IgBPs have been identified in a number of other gram-positive and gram-negative 
bacteria. Protein A from Staphylococcus aureus Cowan 1 was the first IgBP identified (12). 
Protein A inhibits phagocytosis and protein A surface expression is responsible for this 
inhibition (10). Protein A in solution fixes complement by forming IgG:protein A complexes 
(27) and inhibits antibody-dependent cellular cytotoxicity (38). Streptococcal protein H, an 
Fc IgG binding protein, forms soluble complement-activating complexes with IgG but 
decrease complement activation by inhibiting Clq binding to IgG of IgG-coated cells (2). A 
Moraxella catarrhalis IgD-binding protein, MID, activates human B cells and in the presence 
of Th2 cytokines induces immunoglobulin (Ig) secretion (18). Acting as a B cell 
superantigen, protein A activates complement (23), induces expression of Ig from the Vh3 
gene family (25) and increases antigen presentation through soluble protein A:Ig complexes 
associated with Vh3 family surface expressed immunoglobulins (28). It is involved in 
inflammation as demonstrated by the elicitation of an Arthus reaction through administration 
of soluble protein A:Ig complexes (24). Following intraperitoneal immunization of both 
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neonatal and adult Vh3 "knock in"mice with protein A, researchers demonstrated a selective 
suppression in Vh3 expressing IgM secreting cells in both the spleen and liver and a loss of 
detectable Vh3 expressing B-l lymphocytes in the peritoneum (40). In vivo and in vitro 
evidence shows that protein A acts as a B cell superantigen. 
In vivo experiments also indicate a role for IgBPs in virulence. Mice injected with an 
S. aureus protein A deletion mutant require a marginally higher dose of the mutant for 
infectivity and infected mice take significantly longer to succumb to infection and die at a 
slightly decreased rate than mice infected with S. aureus expressing protein A (32). These 
results may have been more dramatic if a recently discovered second S. aureus IgBP, Sbi, 
had also been deleted (49). When immunoglobulin-binding domains of peptostreptococcal 
protein L are expressed on Streptococcus gordonii, vaginal colonization is enhanced and 
colonization persists for a longer time (36). These experiments demonstrate a role for IgBPs 
in virulence although their role has not been clearly elucidated. 
Early work with Gram-positive bacteria focused on utilizing IgBPs as 
immunochemical reagents. For example, protein G binds Igs from a wider range of species 
while protein A binds Igs from fewer species and with lower affinity (5). These features 
have been used to isolate Igs from different species. No work has been published concerning 
the possible relationship between species-specific IgBP binding and species-specific 
infection or concerning a possible relationship between serotype-specific IgBP binding and 
serotype-specific infection. 
Preliminary results in our lab indicated that M. haemolytica might express an IgBP. 
When normal bovine serum (NBS) is used as a negative control to label whole cell M. 
haemolytica in an ELISA, similar absorbance values are obtained with the NBS and with an 
anti-sera specific for an M. haemolytica iron-regulated protein (Tabatabai, unpublished 
results). The objectives of the present study were: 1) To identify and isolate an M. 
haemolytica IgBP, 2) To determine the presence or absence of IgBP surface expression, 3) 
To determine whether there is an increased antibody response to the IgBP in cattle 
convalescing from BRD, 4) To determine whether the IgBP may play a role in the dominance 
of ST1 association with BRD or the dominance of ST2 in sheep mannheimiosis. 
Materials and Methods 
Bacterial isolates 
M. haemolytica ST 1 (isolate LI01) was isolated from an infected bovine lung (14). 
Serotypes 1,2, 5-9, 12-14, and 16 (3, 33, 11) were gifts from G. Frank (USDA/ARS National 
Animal Disease Center, Ames, Iowa). Serotype 17 (48) was unavailable for this study. 
Haemophilus somnus strain 8025 was a gift from Ron Griffith (Iowa State University). 
Whole cell sonicate and supernatant preparations 
Cells stored at -70°C were cultured overnight on blood agar plates, colonies 
transferred and cultured with shaking in 3 ml RPMI (Sigma; St. Louis, MO) with 20mM 
HEPES (pH 7.2) for 6 hours at 37°C. Ten ml of these cultures were used to culture 1 L 
RPMI for 20 hours with shaking at 37°C. The culture was centrifuged (6,000 x g for 20 
minutes) and the CS was retained and stored at -70°C. The cell pellet was washed with 0.1M 
phosphate buffered saline (PBS), pH 7.2, and centrifuged (6,000 x g for 20 minutes) three 
times. The cells were lysed in water. The lysate was sonicated for four minutes (4 cycles of 
1" on, 1 "off, power at 7, duty cycle at 8) using a Branson Sonifier 250. The lysate was 
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ultracentrifuged (50,000 x g for 2 hours at 4°C). The supernatant was retained as the whole 
cell sonicate (WCS) preparation, dialyzed in 5 mM NH4HCO3 (pH 7.2), aliquoted and stored 
at -70°C. Prior to IgBP affinity isolation, M. haemolytica WCS was dialyzed in 50 mM Tris 
(pH 8.0). This procedure was used for all M. haemolytica serotypes and H. somnus 8025. 
Gel electrophoresis and immunoblotting 
SDS-PAGE was conducted on denatured M. haemolytica WCSs, CS and isolated 
IgBP in 12.5% acrylamide gels with a 4% acrylamide stacking gel (26). Protein 
concentrations for all preparation were determined by Folin-Lowry (29). Proteins were 
transferred onto 0.45p,m Protran nitrocellulose (Schleicher & Schuell, Keene, NJ) using a 
Bio-Rad Trans-Blot Cell apparatus. Nitrocellulose blots were blocked with 0.25% fish 
gelatin (Norland Products, Inc., New Brunswick, NJ ) in 0.1 M PBS, pH 7.2 for 15 minutes. 
In far-Western blots, which detect non-antibody mediated protein:protein interactions, 
transferred IgBP was bound to bovine Fc IgG by incubating nitrocellulose blots overnight in 
bovine Fc IgG (44 jj.g/10 ml 0.1M PBS, pH7.2, Jackson Laboratories, West Grove, PA) or 
sheep Fc IgG (180 p.g/10 ml 0.1 M PBS, pH7.2, Jackson Laboratories, West Grove, PA). In 
Western blots, which detect antigen:antibody interactions, transferred WCS was incubated 
with cattle sera (1:100) in 0.25% fish gelatin, 0.1 M PBS, pH 7.2. After washing (0.1 M PBS, 
pH 7.2 with 0.05% Tween 80) the blots were developed with horseradish-peroxidase (HRP)-
conjugated rabbit anti-bovine Fc IgG, sheep Fc IgG or bovine IgG. 
Bovine antisera 
Sera from acutely infected animals were obtained from 10 feed yard calves three days 
after experimental infection with M. haemolytica. Sera from convalescent animals were 
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collected two weeks post-infection. The log2 indirect hemagglutination titers (14) ranged 
from 4 to 7 for the infected calves and from 7 to 10 for the convalescent calves. 
Affinity isolation 
Cyanogen bromide (CNBr)-activated Sepharose 4B (Sigma, St. Louis, MO) was 
coupled to bovine gamma globulin (Jackson Immunoresearch Labs, West Grove, PA) 
according to manufacturer's procedure. M. haemolytica WCS in 50 mM Tris (pH 8.0) was 
adsorbed with bovine gamma globulin-Sepharose 4B by rotating the sample for 48 hours at 
4°C. IgBP was eluted from the Sepharose in a column with 0.9% NaCl-lM propionic acid. 
IgBP was concentrated by Speedvac vacuum concentration (Savant, Holbrook, NY). 
Flow cytometry 
M. haemolytica whole cells were blocked with 0.25% fish gelatin in 0.1 M PBS (pH 
7.2) for 15 minutes at room temperature before labeling. Cells (0.5x 106) were labeled with 
either 0.1 M PBS (pH 7.2) or 1.9 mg bovine Fc IgG (Jackson Immunoresearch Laboratories, 
West Grove, PA) for two hours at room temperature. Fluorescein isothiocyanate (FITC) 
labeled goat F(ab')a anti-bovine IgG, Fc fragment specific (Jackson Immunoresearch 
Laboratories) was conjugated to all cells for two hours at room temperature. Cells were 
washed across a 0.22 p.m filter five times (0.1M PBS, pH 7.2 with 0.05% Tween-80) before 
and after adding conjugate. The final wash after incubation of cells in conjugate was done 
with 0.01 M PBS, pH 7.2. Fluorescence was detected on a Beckman Coulter EPICS XL-
MCL (Miami, FL). Absorbance was at 488 nm and emission was read at 550 DL/525 BP. 
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Results 
Identification of M. haemolytica-^pressed IgBP(s) 
Both WCS and CS preparations from M. haemolytica ST1 expressed at least one 
IgBP as seen on an immunoblot (Fig. 1). A dominant band at 75.0 kDa, a band at 40.7 kDa 
and several less distinct bands ranging from 74.9 kDa to 62.0 kDa were present in both WCS 
and CS preparations. A band at 107.5 kDa was present only in the supernatant. Although the 
M, haemolytica supernatant was at a higher concentration than the WCS preparation in this 
immunoblot, the 107.5 kDa band appeared to be unique to the supernatant as this band did 
not appear when concentrated isolated IgBP(s) was run on SDS-PAGE at higher 
concentrations (Fig. 2). The H. somnus WCS preparation was a positive control known to 
express IgBPs (46). No binding was evident between the conjugate and the WCS or 
supernatant preparations (results not shown). 
Isolation of M. haemolytica-expressed IgBP 
M. haemolytica IgBP(s) was isolated by affinity chromatography (Fig. 2). An M. 
haemolytica WCS preparation was adsorbed with CnBr activated-Sepharose 4-B to which 
bovine gamma globulin had been bound. IgBP(s) was eluted in a column with 1 M propionic 
acid in 0.9% NaCl. At the IgBP concentration collected in the fractions, bands are seen at 
77.2, 63.2 and 40.2 kDa. After IgBP fractions were concentrated by vacuum centrifugation, 
additional bands were evident at 168.7, 132.5, 56.5, and 20.0 kDa. All bands were able to 
bind bovine Fc IgG as seen on far-Western blot (results not shown). Efforts to determine the 
N-terminal sequence of the 77.2 and 20.0 kDa bands were unsuccessful. The N- terminus 
might be blocked or there may have been insufficient protein to be sequenced. 
Surface expression of M. haemolytica IgBP 
Whole cell M. haemolytica (0.5x10* cells) were labeled with bovine Fc IgG or PBS. 
Bovine Fc IgG bound to whole cells was detected with FITC-conjugated goat F(ab'): anti-
bovine IgG, Fc fragment specific. Propidium iodide incorporated M. haemolytica cells were 
used to the set the gate identifying M. haemolytica whole cells. Flow cytometry 
measurements showed that the number of FITC positive cells was increased by 64.9 % on M. 
haemolytica whole cells labeled with bovine Fc IgG compared to PBS labeled cells (Fig. 3). 
Humoral immunogenicity of an M. haemolytica IgBP 
Sera from naïve cattle, acutely infected cattle and convalescent cattle were used to 
probe an M. haemolytica WCS preparation in a Western blot. Binding was detected with an 
HRP-conjugated rabbit anti-bovine Fc IgG. The humoral immune response to the dominant 
75.0 kDa IgBP was increased in convalescent cattle when compared to naïve or acutely 
infected cattle (Fig. 4). The location of the IgBP in the WCS preparation was identified in 
lane c. This lane shows the WCS preparation probed with bovine Fc IgG. H. somnus in lane 
b was a positive control. 
Involvement of IgBP from different serotypes with species-specific infection 
M. haemolytica WCS preparations from all serotypes (1,2, 5-9, 12-14, and 16) were 
probed with either bovine Fc IgG or sheep Fc IgG in a far-Western blot (Fig. 5 and 6). 
Detection was with HRP-conjugated rabbit anti-bovine or anti-sheep Fc IgG. The same 
WCS preparation was used for both blots and all lanes have the same concentration of M. 
haemolytica WCS. At the conjugate dilution used, rabbit immunoglobulin (Ig) binding to M. 
haemolytica IgBP(s) was not apparent (Results not shown). 
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All serotypes bound both bovine Fc IgG and sheep Fc IgG (Fig. 5 and 6). The 
banding patterns found by probing with either bovine Fc IgG or sheep Fc IgG were quite 
dissimilar. More bands were evident with sheep Fc IgG binding than with bovine Fc IgG 
binding. The dominant bands detected from bovine Fc IgG binding were 74.1 63.5 and 33.2 
kDa whereas the dominant sheep Fc IgG IgBP(s) bands were 58.4 and 50.1 kDa. 
Serotypes 1 and 2 both bound bovine Fc IgG with dominant bands at 74.1 and 63.5 
kDa (Fig. 5). There was no significant difference between the serotypes in the intensity of 
the staining of either band. The 74.1 kDa band was more intense in both serotypes. Serotype 
2 had an additional band at 33.2 kDa that was not evident in ST 1. The remaining serotypes 
had various similar IgBP binding patterns and no serotype has a band that is unique to that 
serotype alone. 
Serotype 1 bound sheep Fc IgG less intensely than ST2 binds sheep Fc IgG (Fig. 6). 
Although both serotypes had similar binding patterns, ST2 IgBPs bound sheep Fc IgG more 
intensely at 79.4, 58.4, 50.1, 30.1 and 24.7 kDa than did ST1. Serotypes 5, 8, 13 and 14 had 
intense bands 58.4 kDa although all serotypes expressed an IgBP that binds at 58.4 kDa. 
Generally, all serotypes had a similar sheep Fc binding pattern. 
Discussion 
This study showed that an IgBP(s) present in WCS and CS preparations binds bovine 
Fc IgG as shown on far-Western blot (Fig. 1). Both preparations have a dominant band at 
75.0 kDa and a less intensely staining band at 40.2 kDa. This suggests that the same protein 
or proteins is expressed in the WCS and supernatant. Both bands are of similar intensity in 
the WCS and CS preparations although the CS has almost twice the amount of total protein 
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in lane b as compared to the WCS in lane a. This could indicate that less IgBP(s) is secreted 
than is cell bound. The supernatant preparation has an additional band at 107.5 kDa. This 
band appears unique to the supernatant because isolated, concentrated IgBP(s) from a WCS 
preparation in figure two shows a number of additional bands on SDS-PAGE but no band 
comparable to the 107.5 kDa band found in the supernatant. 
Numerous molecular weight (MW) determinations by SDS-PAGE have shown the 
dominant M. haemolytica IgBP to have MW ranging from 58.0 kDA to 77.2 kDa. Molecular 
weight variability is indicative of elongated molecules. Protein A displayed a variable MW 
(40.2 kDa to 56.0 kDa) and is an elongated molecule (4). This suggests that the dominant M. 
haemolytica IgBP may be an elongated molecule. 
There are a number of possible explanations for the appearance of more than one 
IgBP band on far-Western blot. IgBPs from other organisms have repeat binding sites for Fc 
Ig. Protein A has five (30) while protein G has three repeat Fc Ig binding regions (19). It is 
possible that the different M. haemolytica IgBP(s) bands evident on far-Western blot are due 
to the IgBP(s) expressing a different number of Fc IgG binding sites which would result in 
number of different molecular weight bands. Multiple bands could also be due to a unique 
protein in each Western blot band or the bands might be degradation products of one or more 
proteins. There is evidence for the latter possibility as seen by SDS-PAGE of the isolated, 
concentrated IgBP (Fig. 2). 
Mannheimia haemolytica IgBP(s) was isolated by affinity chromatography by 
binding bovine gamma globulin to CNBr-activated Sepharose (Fig. 2). When affinity-
isolated IgBP(s) is concentrated (Fig. 2, lane c), five additional bands are evident. The 63.2 
and 22.4 kDa bands appear to be breakdown products of larger proteins because these bands 
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are much more intense when the affinity-isolated IgBP(s) was concentrated while the 77.2 
KDA band is of equal intensity in both preparations. Further work with the isolated protein 
is planned in an effort to compare the M. haemolytica IgBP(s) to other better-characterized 
IgBPs from gram-positive bacteria. 
Several M. haemolytica IgBP(s) characteristics determined in this study indicate a 
role for the IgBP in virulence. First, flow cytometry shows the IgBP(s) to be surface 
expressed on M. haemolytica (Fig. 3). Surface expression of protein H, an Fc IgG-binding 
protein from Streptococcus pyogenes, reduces phagocytosis of the bacteria (22) and inhibits 
complement activation by blocking C3 deposition on the bacterial surface (2). Increased 
protein A surface expression on S. aureus leads to increased inhibition of phagocytosis (10). 
These virulence mechanisms may be active in M. haemolytica. Secondly, this study 
identifies a secreted form of the M. haemolytica IgBP. Soluble protein A reduces antibody-
dependent cellular (38) and fixes complement in solution thus consuming complement 
components (42). Soluble protein H interacts with IgG to form complement-activating 
complexes (2). Thus, the CS IgBP(s) may play a role in inhibiting phagocytosis and limiting 
complement activation as well as consuming soluble complement components. Lastly, 
convalescent cattle had an increased antibody response to the 70.5 kDa M. haemolytica IgBP 
when compared to naïve or acutely infected cattle (Fig. 4). The increased antibody response 
in convalescent cattle suggests that an immune response to the IgBP(s) may be important in 
protection.. These results indicate a role in virulence for the M. haemolytica IgBP(s). 
M. haemolytica ST1 is generally associated with BRD in cattle (15, 44) and ST2 is 
most frequently associated with pneumonic mannheimiosis in sheep (16). In an effort to 
determine whether the M. haemolytica IgBP(s) is a factor in serotype-specificity of species-
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specific infection, far-Western blots were run to determine whether differences are evident 
between binding of bovine Fc IgG or sheep Fc IgG to STl and ST2 and whether bovine Fc 
IgG and sheep Fc IgG binds to all 12 serotype WCS preparations regardless of whether they 
are known to be involved in infection. Differences among infectious serotypes or between 
infectious and noninfectious serotypes might indicate a role for serotype-specific infection in 
cattle and sheep. Serotypes 1 and 2 both bind bovine Fc IgG and have protein bands at 74.1 
and 63.5 kDa that stain with similar intensity in the two serotypes (Fig. 5). The 74.1 kDa 
band appears equally dominant in these two serotypes. A 33.2 kDa band is evident in ST2 
that is not found in STl. It is possible that this difference is responsible for serotype-
specificity of infection in cattle and sheep. However, the remaining serotypes express the 
33.2 kDa protein band and these are not typically isolated from infections in sheep. This 
suggests that M. haemolytica expressed IgBPs do not play a role in serotype-specificity in 
infection of cattle. All 12 serotypes express an IgBP that binds bovine Fc IgG and all 
serotypes have similar banding patterns. No serotype has a protein band that is unique to that 
serotype. This is further evidence that M. haemolytica IgBP(s) does not play a role in the 
dominance of STl found in infections in cattle. Differences among the serotypes in binding 
bovine Fc IgG may be due to; 1) serotypes expressing dissimilar amounts of IgBP(s), 2) 
different serotypes expressing IgBP(s) with diverse numbers of Fc IgG binding sites, 3) M. 
haemolytica expressing more than one bovine Fc IgG IgBP in different serotypes. 
Serotype 2 binds sheep Fc IgG more intensely than does STl (Fig. 6). However, as in 
bovine Fc IgG binding, other serotypes not known to be infective have protein-banding 
patterns as intense as found with ST 2. This would suggest that the difference found between 
ST land ST2 is not responsible for serotype-specific infection in sheep. All serotypes bind 
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sheep Fc IgG in a similar protein-banding pattern. Four serotypes (5, 8, 13 and 14) have a 
particularly dominant band at 62.1 kDa. What role, if any, this may play in bacterial 
virulence or lack of virulence in these serotypes is not known. 
Bovine Fc IgG bound to M. haemolytica IgBP(s) in a different protein-band pattern 
than sheep Fc IgG in all STs. M. haemolytica may express only one IgBP that has separate 
binding sites for sheep Fc IgG and bovine Fc IgG or M. haemolytica may express different 
proteins for binding bovine Fc IgG and sheep Fc IgG. Whether or not this plays any role in 
virulence is not known and is again doubtful because these same differences occur among 
infective serotypes and non-infective STs. 
The fact that all serotypes express an IgBP(s) but not all serotypes are infective could 
indicate that the IgBP(s) are not involved in virulence. However, several lines of evidence 
demonstrate that this may not be true: 1) Protein A from S. aureus (41) and protein H from 
Streptococcus pyogenes are surface expressed. The M. haemolytica IgBP(s) was also shown 
to be surface expressed. Protein A and protein H surface expression inhibits phagocytosis 
(10, 22). 2) Convalescent cattle show an increased antibody response to M. haemolytica ST 
1 IgBP. 3) M haemolytica IgBP(s) may be a virulence factor in infection of cattle and sheep 
but may not be a factor sufficient by itself to cause infection. 
In summary, this study identifies an M. haemolytica surface expressed IgBP(s) as 
well as a secreted IgBP(s). The IgBP(s) does not appear to play a role in serotype-specificity 
of species-specific infection as all serotypes bind both bovine Fc IgG and sheep Fc IgG. 
However, sheep Fc IgG binds M. haemolytica IgBP(s) with a different protein band pattern 
on far-Western blot than does bovine Fc IgG. This difference may indicate a different 
virulence role for the IgBP(s) in cattle and sheep but more likely it may be that more than one 
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IgBP may be expressed by M. haemolytica or there are different binding sites for sheep Fc 
IgG and bovine Fc IgG. The M. haemolytica IgBP(s) from the WCS preparation was isolated 
by affinity chromatography. Western blot results in this study showed an increased antibody 
response to M. haemolytica IgBP in cattle recovering from mannheimiosis indicating a 
Gpossible role for the IgBP in protection from M. haemolytica induced BRD. The in vivo 
and in vitro virulence association of protein A and other previously identified IgBPs, the 
similarity in surface expression of protein A, protein H and M. haemolytica IgBP(s), the 
presence of a secreted M. haemolytica IgBP(s) and the increased immune response to an M. 
haemolytica IgBP in convalescent cattle suggest a role for M. haemolytica IgBP in virulence. 
The M. haemolytica IgBP may be an important factor in future subunit vaccines. 
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FIG. 1. Far-Western blot identification of an IgBP expressed by M. 
haemolytica. Lanes: a, 7.0 (ig M. haemolytica WCS; b, 12.0|ig M. 
haemolytica supernatant; c, 36.0 jag H. somnus WCS. All lanes were probed 
with 0.58 mg bovine Fc IgG and developed with HRP-conjugated rabbit anti-
bovine IgG, Fc fragment specific (1:1000). Location of molecular size 
markers is indicated on the left. All molecular weights are in kDa. 
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FIG. 2. SDS-PAGE of IgBP isolation from M. haemolytica WCS. Lane: a, MW 
markers; b, 0.35 \ig IgBP isolated from M. haemolytica WCS; c, 3.50 |ig isolated, 
speed-vacuum concentrated IgBP from M. haemolytica. IgBP was isolated on a 
bovine gamma globulin-CNBr Sepharose column. All molecular weights are in 
kDa. 
71 
PBS 
5.4% 
11 urn 1 i mill 
1888 
i 11 mil 
FLl LOG 
Bovine Fc IgG 
70.3% 
FLl LOG 
Bovine Fc IgG 
FIG. 3. Flow cytometry analysis of whole cell M. haemolytica IgBP surface expression. (A) 
Whole cell M. haemolytica (0.5x106) labeled with 0.1M PBS, pH 7.2. (B) Whole cell M. 
haemolytica (0.5x10*) labeled with 1.9 mg bovine Fc IgG in PBS. FITC-conjugated rabbit 
F(ab')2 anti-bovine IgG, Fc fragment specific revealed the presence of bound bovine Fc IgG. 
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FIG. 4. Antibody responses to M. haemolytica WCS IgBP in pooled sera from naïve, 
acutely infected and convalescent cattle. Lanes: a, MW markers; b, H. somnus 
WCS; c, 7.2 (ig isolated M. haemolytica IgBP; d, e, f, 7.0 j-ig M. haemolytica WCS. 
Lanes a, b and c were probed with 0.58 mg bovine Fc IgG. Lane d was probed with 
naïve cattle sera. Lane e was probed with sera from cattle with acute M. haemolytica 
infection. Lane f was probed with sera from cattle convalescing from M. haemolytica 
induced BRD. Cattle sera were diluted 1:100. All binding was detected with HRP-
conjugated rabbit anti-bovine IgG, Fc fragment specific. 
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FIG. 5. Bovine Fc IgG binds to all serotypes of M. haemolytica WCS 
preparations. In a far-Western blot, SDS-PAGE separated proteins from lO.Ojug M. 
haemolytica WCS preparations from all serotypes were transferred onto 
nitrocellulose and probed with bovine Fc IgG (0.5 mg). Blots were developed with 
HRP-conjugated rabbit F(ab')a anti-bovine Fc IgG. Molecular weight markers are 
in the first lane. The serotype of each M. haemolytica WCS preparation is 
identified above succeeding lanes. The molecular weight of all bands resulting 
from bovine Fc IgG binding is indicated on the right. 
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FIG. 6. Sheep Fc IgG binds to all serotypes of M. haemolytica WCS preparations. In a 
far-Western blot, SDS-PAGE separated proteins from M. haemolytica WCS 
preparations from all serotypes (10.0 jug each) were transferred onto nitrocellulose and 
probed with sheep Fc IgG (0.5 mg). Blots were developed with HRP-conjugated rabbit 
F(ab')2 anti-sheep Fc Ig. Molecular weight markers are in the first lane. The serotype 
of each M. haemolytica WCS preparation is identified above each lane. The molecular 
weight of all bands resulting from bovine Fc IgG binding is indicated on the right. 
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CHAPTER 3. FIBRINOGEN- AND FIBRONECTIN-BINDING AND IN VITRO 
GROWTH CONDITION-DEPENDENT EXPRESSION OF A MANNHEIMIA 
HAEMOLYTICA IMMUNOGLOBULIN-BINDING PROTEIN 
Ruth Smith Osmundson and Louisa B. Tabatabai 
A paper to be submitted to Infection and Immunity 
Abstract 
Bovine respiratory disease (BRD) is the cause of large losses to the cattle industry 
annually and is primarily caused by Mannheimia haemolytica serotype (ST) 1. M. 
haemolytica, a normal flora respiratory tract bacteria, rapidly multiplies upon a stressful 
occurrence and colonizes the upper respiratory tract. Extra-cellular matrix proteins (ECMPs) 
are known to play a role in colonization by some bacteria by acting as a bridge enabling 
binding between bacteria expressing extracellular matrix-binding proteins (ECMBPs) and 
epithelial cells. A previously identified immunoglobulin-binding protein (IgBP) expressed 
by M. haemolytica was shown here to have bound the ECMPs fibrinogen (Fg) and 
fibronectin (Fn) Far-Western blot results demonstrated that the isolated IgBP bound bovine 
Fc IgG and either Fg or Fn simultaneously. The effect of various M. haemolytica growth 
conditions on IgBP expression was assessed by 2-D gel electrophoresis analysis. Membrane 
expression of M. haemolytica IgBP was increased in growth conditions more closely 
replicating in vivo conditions. IgBP expression was increased a minimum of twofold when 
M. haemolytica was grown in RPMI-1640 media with 2,2'-dipyridyl, and threefold when M. 
haemolytica was grown in RPMI-1640 supplemented with 10% fetal bovine sera (FBS) and 
76 
RPMI-1640 at 40°C when compared to IgBP expression when M. haemolytica was grown in 
RPMI-1640 at 37°C. Up to 19.9% of M. haemolytica membrane proteins were IgBPs when 
M. haemolytica was grown in RPMI at 40°C. This study shows a possible increased role in 
virulence for the previously identified M. haemolytica IgBP. It may play a role in 
colonization through binding Fg or Fn and is a highly expressed protein when M. 
haemolytica is grown under conditions mimicking aspects of in vivo conditions. 
Introduction 
Bovine respiratory disease (BRD) has a complex etiology but pneumonic 
pasteurellosis, more commonly called shipping fever, is believed to be caused by 
Mannheimia haemolytica. M. haemolytica serotype (ST2) is a normal flora bacteria of the 
upper respiratory tract (URT) in cattle but on occurrence of a stressful incident such as viral 
infection or shipping from farm to feedlot, isolates of M. haemolytica shift from ST2 to ST1 
and can grow explosively colonizing the URT (Frank 1979; Frank and Smith, 1983). The 
bacteria are believed to be inhaled into the lungs. This is followed by an influx of 
neutrophils into the lungs, serum flooding, and an inflammatory response that leads to 
fibrinohemorrhagic pneumonia. Morbidity and mortality due to shipping fever are among 
the leading causes of economic loss in the cattle industry. 
Adherence to epithelial cells is a necessary component for M. haemolytica 
colonization of the URT in cattle. The surface components used by M. haemolytica to adhere 
to airway epithelial cells are not known. Two types of fimbrae, a large, rigid fimbrae (Morck 
et al., 1987) as well as smaller, flexible fimbrae (Potter, et al., 1988) have been reported but 
fimbrae have not yet been found in M. haemolytica isolated from the lung or URT of cattle 
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(Gonzalez and Maheswaran, 1993). In addition, their role in attachment has not been 
demonstrated. A number of Gram-negative bacteria express adhesins that are distinct from 
fimbrae (Minion et al., 1986 and Moo et al., 1992). Identification of an M. haemolytica 
adhesive surface component would open the door to development of a treatment that could 
decrease colonization and result in reduced development of pneumonic pasteurellosis. 
Bacteria bind to host cells when bacterial cell surface components adhere to host cell 
components or to host extracellular matrix proteins (ECMPs) that bind host cells and act as a 
bridge between bacteria and host cells. The latter group of adhesive bacterial cell surface 
components is termed extracellular matrix-binding proteins (ECMBPs), adhesins, microbial 
surface components recognizing adhesive matrix molecules (MSCRAMMs), or receptins. 
ECMBPs from Staphylococcus aureus are best characterized and include proteins that bind 
fibronectin (Fn), collagen and a secreted protein that binds fibrinogen (Fg) (Flock, 1999). 
One S. aureus ECMBP, extracellular adherence protein (Eap), binds seven plasma proteins 
including Fg and Fn (Palma et al., 1999). A number of Gram-negative organisms express 
ECMBPs including Eschericia coli (Westerland et al., 1989), Haemophilus ducreyi (Abeck et 
al., 1992), H. influenza (Fink et al., 2002), Neisseria gonorrhoeae (van Putten et al., 1998) 
and Borellia burgdorferi (Probert and Johnson, 1998). In addition, a number of 
immunoglobulin-binding proteins are known to bind ECMPs. For example, Protein H, 
present in some strains of S. pyogenes and first known to bind Fc IgG, also binds fibronectin. 
A fibronectin binding protein also from S. pyogenes, Sfbl, has been shown to bind Fc IgG 
(Frick et a., 1995; Medina et al., 1999). A Group C streptococci has been shown to express 
protein F AI which binds fibrinogen, albumin and IgG (Talay et al., 1996). In addition, 
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FgBP, a fibrinogen-binding protein of Streptococcus equi, has recently been shown to bind 
equine Fc IgG (Meehan et al., 2001). 
ECMBPs are believed to contribute to virulence in a number of bacteria. Mongodin 
et al. (2002) established that a fibronectin-binding protein-deficient strain of S. aureus has a 
fivefold-decrease in the level of adherence to human airway epithelial cells suggesting that 
Fnbps are involved in adherence. An isogenic mutant unable to produce the Fn- and Fg-
binding protein of Streptococcus suis ST2 shows decreased colonization of piglets in the 
joints and central nervous system, organs specifically involved in S. suis infection (de Greeff, 
et al., 2002). In vitro models demonstrate several additional roles for ECMBPs in virulence. 
In the presence of Fn and an anti-CD3 monoclonal antibody, S. aureus FnbpA mediates 
adhesion to T cells and T cell costimulation through the T cell asPi integrin, which binds Fn 
and functions as a costimulatory molecule, leading to T cell activation (Miyamoto et al., 
2001). A T helper type 2 inflammatory environment promotes S. aureus binding to skin and 
this binding is mediated by Fn and Fg (Cho et al., 2001). ECMBPs appear to have a variety 
of roles in virulence. 
The mechanism for the abrupt change from the predominance of the normal flora M. 
haemolytica ST2 to explosive growth of stress-associated ST1 is not known. However, 
change in host environmental factors due to stress is likely to play a role. In an effort to 
recreate in vivo protein expression while using in vitro systems and also to define culture 
conditions that affect expression of particular proteins, a number of studies have been done to 
define protein expression under different culture conditions. Shewen and Wilkie (1982) 
reported that the addition of 7% fetal bovine serum (FBS) to RPMI-1640 tissue culture media 
achieves enhanced M. haemolytica production of leukotoxin, a secreted RTX cytolysin, 
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compared to tissue culture media alone. Iron-regulated outer membrane proteins of 71, 77 
and 100 kDa are expressed at higher levels in iron-restricted media (Deneer and Potter, 
1989; Morck et al., 1991). M. haemolytica OMP protein expression was compared between 
bacteria that were isolated from lungs of experimentally infected calves to bacteria cultured 
under various in vitro growth conditions. OMP expression profiles on SDS-PAGE arre 
similar for M. haemolytica isolated from lungs and M. haemolytica grown in newborn calf 
serum (Davies et al., 1994). No capsular polysaccharide production is detected when M. 
haemolytica is grown above 40°C (Puente-Polledo et al., 1998). Experiments by Reeve-
Johnson et al. (2001) noted higher clinical scores in calves with temperatures of 39.9-41.0°C 
compared to normal temperatures of 39.2°C. In addition, pathogens are known to upregulate 
or downregulate expression of adhesive components under varying conditions of the host 
environment (Finlay and Falkow, 1989; Francis et al., 1989; Mekalanos, 1992). Establishing 
in vitro growth conditions that closely mimic in vivo conditions may increase the efficacy of 
vaccines prepared from in vitro M. haemolytica cultures. 
The hypotheses for this study were that a previously identified M. haemolytica ST1 
immunoglobulin-binding protein (IgBP) binds one or more ECMPs and that this protein 
would be upregulated when grown under m vitro growth conditions that more closely mimic 
in vivo conditions. 
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Material and Methods 
Bacterial isolate and growth conditions 
M. haemolytica ST1 (isolate LI01) was isolated from an infected bovine lung (Frank 
and Smith 1983). 
Fetal bovine sera 
FBS was obtained from National Animal Disease Center, Ames, Iowa. It was heated 
to 56°C for 25 min before use. 
IgBP isolation 
Cyanogen bromide (CNBr)-activated Sepharose 4B (Sigma, St. Louis. MO) was 
coupled to bovine gamma globulin (Jackson Immunoresearch Labs, West Grove. PA) 
according to manufacturer's procedure. M. haemolytica WCS in 50 mM Tris (pH 8.0) was 
adsorbed with bovine gamma globulin-Sepharose 4B by rotating the sample for 48 hours at 
4°C. IgBP was eluted from the Sepharose in a column with 0.9% NaCl-lM propionic acid. 
IgBP was concentrated by Speeedvac vacuum concentration (Savant, Holbrook, NY). 
Gel electrophoresis and immunoblotting 
SDS-PAGE was conducted on denatured M. haemolytica WCS, isolated IgBP, Fn 
(from bovine plasma, Sigma, St. Louis MO) and Fg (from bovine plasma, Sigma, St. Louis, 
MO) in 12.5% acrylamide gels with a 4% acrylamide stacking gel (Laemmli, 1970) or 4-12% 
Bis-Tris polyacrylamide gels (Invitrogen, Carlsbad, CA). Protein concentrations for all 
preparations were determined by Folin-Lowry (Lowry et al., 1951). Proteins were 
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transferred onto 0.45(im Protran nitrocellulose (Schleicher & Schuell, Keene, NJ) using a 
Bio-Rad Trans-Blot Cell apparatus. Nitrocellulose blots were blocked with 0.25% fish 
gelatin (Norland Products, Inc., New Brunswick, NJ ) in 0.1M PBS, pH 7.2 for 15 minutes. 
Transferred IgBP was detected by incubating nitrocellulose blots overnight in bovine Fc IgG 
(44 jug/10 ml, Jackson Laboratories, West Grove, PA). After washing (0.1M PBS, pH 7.2 
with 0.05% Tween 80) the blots were developed using horseradish-peroxidase (HRP)-
conjugated rabbit antibodies to fibronectin (1:1000) or bovine Fc IgG (1:1000). 
WCS and membrane protein preparation 
Cells stored at -70°C were cultured overnight on blood agar plates (Becton 
Dickinson, Sparks, MD), colonies transferred and cultured in 3 ml RPMI-1640 (Sigma; St. 
Louis, MO) with 20mM HEPES (pH 7.2) for 6 hours at 37°C with shaking and 10 ml was 
used to culture 1 L RPMI-1640 at 37°C, RPMI-1640 with 50 |aM 2,2'-dipyridyl at 37°C. 
RPMI-1640 with 10% FBS at 37°C, or RPMI-1640 at 40°C for 20 hours with shaking. 
Optical density readings were taken at 600 nm on a Beckman DU 640 spectrophotometer 
(Beckman, Fullerton, CA). Streaking on blood agar plates checked purity. The culture was 
centrifuged (6,000 x g for 20 min). The cell pellet was washed with 0.01 M phosphate 
buffered saline (PBS), pH 7.2, and centrifuged (6,000 x g RPMI-1640 for 20 minutes) three 
times. After washing the pellet two more times, the pellet was resuspended in 0.01 M PBS 
(pH 7.2) and sonicated on ice for four minutes (8 cycles of 30 sec on, 30 sec off, power at 7, 
duty cycle at 5) using a Branson Sonifier 250. The sonicated cells were centrifuged (6000 x 
g for 20 min) and the supernatant was ultracentrifuged (50,000 x g for 2 hours at 4°C). The 
supernatant was retained as the WCS and the pellet, the membrane preparation, was 
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resuspended in 50 mM Tris HC1, pH 7.5 containing 50 jag /ml phenylmethylsolfonylfluoride 
(PMSF) (Sigma). The solution was set on ice for 1 h and protein concentrations were 
determined using Amersham Bioscience's PlusOne 2-D Quant kit (San Francisco, CA). 
2-D gel electrophoresis 
Membrane samples (50 pig protein/50 (il) were added to 75 |il rehydration buffer 
(0.5% v/v carrier ampholytes, pH 3-10 (Amersham Bioscience, San Francisco, CA), 2M 
thiourea, 2mM tributylphosphine (TBP), 1 % w/v tetradecanoylamido-propyl-dimethyl 
ammonia-propane-sulfonate (ASB-14), 2% w/v CHAPS, 8M urea, 0.5% IPG buffer, pH3-10 
(Amersham Bioscience), 10 ml E-pure water and 0.2% Pefabloc (Boehringer Ingelheim 
(Ingelheim, Germany), and 0.28 mg dithiothriotol (Sigma) were added. The samples were 
briefly centrifuged to remove particulate matter and 125 jo.1 of each sample was loaded onto 
Immobiline IPG DryStrip gels (7 cm, pH 3-10,) (Amersham Biosciences). Strips were 
rehydrated for lOh at 30°C and proteins were focused on an IPGphor electrophoresis unit 
(Amersham Bioscience) for approximately 33kVh as follows: 
Volts 500 1000 2000 4000 6000 8000 
Hours 1:30 1:30 1:00 1:00 1:00 5:00 
IPG strips were equilibrated in SDS equilibration buffer [50mM Tris-HCl (pH 8.8), 6 M 
urea, 30% (v/v) 87% glycerol, 2% (w/v) SDS, trace bromophenol blue in E-pure water] with 
100 mg dithiothreitol/10 ml buffer for 15 min. Then IPG strips were equilibrated in SDS 
equilibration buffer with 250 mg iodoacetamide/10 ml solution for 15 min. Strips were 
sealed in place on top of an SDS-PAGE gel using 0.5% agarose in SDS electrophoresis 
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buffer containing bromophenol blue, SDS-PAGE was carried out on 4-12% Bis-Tris gel 
(Invitrogen) polyacrylamide gels using MOPS Running Buffer (Invitrogen). NuPAGE 
antioxidant (0.25%) (Invitrogen) was added to the cathode buffer. Second-dimension 
electrophoresis was carried out using 15mA/gel constant current for 15 min then at 200V 
(constant voltage)for 45 min in a Mighty Small II electrophoresis unit (Hoeffer Scientific 
Instruments, San Francisco, CA). Gels were stained overnight with 0.1% Coomassie 
Brilliant Blue R-250 in 50% methanol and 10% acetic acid. Gels were destained in 25% 
ethanol and 10% acetic acid and imaged on an Amersham Biosciences Image Scanner. 
2-D gel analysis 
Far-Western blot and 2-D gel analysis were done using PDQuest 6.1 gel analysis 
software (Bio-Rad Laboratories, Hercules, CA). A match set was created with all four gels 
from the four different growth conditions and the far-Western immunoblot identifying 
immunoglobulin-binding protein. Spots identified on the immunoblot were matched to spots 
on the four gels. Spot analysis was performed for each gel. Normalization was done for 
each spot by dividing the raw pixel density quantity of each spot in a member gel by the total 
pixel density quantity of all pixels in the gel image. Pixel density was determined from a 
Gaussian image of each gel. 
Results 
M. heamolytica growth in different in vitro growth conditions 
In vitro growth conditions are usually chosen to support growth. Typical laboratory 
culture conditions for M. haemolytica are growth in a chemically defined media, RPMI-1640, 
at 37°C. To mimic aspects of in vivo growth conditions, M. haemolytica was grown in three 
different culture conditions: RPMI-1640 with 50 pM 2,2'-dipyridyl, RPMI-1640 with 10% 
fetal bovine serum and RPMI-1640 cultured at 40°C. The iron-chelator 2,2'-dipyridyl was 
added to RPMI-1640, a medium without added iron, to chelate any exogenous iron. Most 
pathogenic organisms upregulate a number of proteins under iron-restricted conditions 
(Gray-Owen and Schryvers, 1996). Fetal bovine sera (10%) was added to RPMI-1640 given 
that expression of leukotoxin, a cytolytic toxin secreted by M. haemolytica, is increased in 
vitro when 7% FBS is added to the media (Shewen and Wilkie, 1982). In addition, 
pneumonic mannheimiosis is known to lead to serum flooding in the lungs. Finally, M. 
haemolytica was grown in RPMI-1640 at 40°C because infected cattle have temperatures of 
40°C or above. Normal cattle temperature range is 38.3-38.9°C (discussions with G. Frank, 
NADC, Ames, IA). Growth in RPMI-1640 at 40°C resulted in a culture density almost half 
that of M. haemolytica grown in the same media at 37°C (Table 1). When grown at 40°C, 
pellets of M. haemolytica cells appeaed more viscous than when grown at 37°C. When 10% 
FBS was added to RPMI-1640, cell culture density was nearly twice that of the density of 
cells when grown in RPMI at 37°C. Culture density of M. haemoltyica grown in RPMI-1640 
with the iron-chelator 2,2'-dipyridyl was slightly less than growth in RPMI-1640 at 37°C. 
M. haemolytica IgBP also binds Fg and Fn 
Earlier work indicated that the M. haemolytica IgBP(s) might bind fibronectin. A 
mass-peptide fingerprint of a tryptic digest of one band of the IgBP(s) from an SDS-PAGE 
gel did not establish identity of the IgBP(s) with other proteins in the database (MS-Fit, 
University of California, San Francisco, CA). However, a degree of homology was found to 
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other Fn-binding proteins. Far-Western blots validated that isolated M. haemolytica IgBP(s) 
does bind Fn (Fig. 1, lane 2). One band was evident at 29.8 kDa. To determine whether the 
IgBP(s) would concurrently bind Fn and bovine Fc IgG, Fn was electrophoresed by SDS-
PAGE and electroblotted to nitrocellulose. The blot was incubated with the IgBP(s) in 0.1 M 
PBS and after washing was incubated with bovine Fc IgG in 0.1 M PBS. After washing and 
development with conjugate [rabbit F(ab')z anti-bovine Fc IgG-HRP], the blots revealed that 
the IgBP bound bovine Fc IgG and Fn at the same time (Fig. 1, lane 4). Bands were evident 
at 214.9 and 36.8 kDa (Fig. 1A). No binding was seen on far-Western blot between Fn and 
bovine Fc IgG or Fn and the conjugate (results not shown). The same procedure showed that 
isolated IgBP(s) binds bovine Fc IgG and Fg simultaneously (Fig. 2, lane 2). This lane had 
nine bands ranging from 35.1-159.0 kDa. The control (Fig. 2, lane 5) showed slight 
evidence of conjugate-Fg binding. This lane revealed three faintly evident bands on the blot 
(71.0, 84.5, and 92.2 kDa). 
Comparative analysis of total IgBP pixel density 
IgBP expression was determined by 2-D gel analysis from M. haemolytica grown 
under culture conditions that more closely mimic in vivo conditions. The identity and 
location of the IgBP(s) are shown on the far-Western blot (Fig. 3A). The MW markers are 
indicated (Fig. 3A). The cross hairs indicate the location of the IgBP(s) on the blot and gels 
(Fig. 3, B through F). The pixel density of IgBP spots and total gel pixel density was 
determined with PDQuest 2-D gel analysis software. Dividing spot pixel density by total gel 
pixel density normalized the pixel density value of each spot. Normalization was necessary 
to account for differences in gel loading and/or staining efficiency. 
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Expression of membrane IgBP(s) was increased a minimum of twofold under all test 
conditions while the addition of 10% FBS or growth at 40°C increased IgBP(s)expression at 
least threefold (Table 2). When membrane IgBP expression was analyzed as a percentage of 
total membrane expression, all three test conditions show an approximately twofold increase 
in the percentage of the IgBP(s) compared to the control. Growth conditions of RPMI-1640 
at 40°C yielded the highest percentage membrane IgBP(s)at 19.9%. 
Comparative analysis of individual spot pixel density 
The quantitative relatedness of IgBP spots from each of the three gels generated from 
M. haemolytica grown in RPMI-1640 with 50 (iM 2,2'-dipyridyl, RPMI-1640 with 10% FBS 
and RPMI-1640 at 40°C to the IgBP spots from M. haemolytica grown in RPMI-1640 at 
37°C was determined with PDQuest 2-D gel analysis software. The pixel density of each 
IgBP spot in the gel from M. haemolytica grown in RPMI-1640 at 37° C (x-axis) was plotted 
on a log scale against the corresponding IgBP spot density in each of the three remaining gels 
containing proteins expressed under different conditions. If the spot quantities from the gels 
being compared are equal, the indicating dot will appear on the regression line with a slope 
of one. Deviations indicate an increase or decrease in expression for a given spot between 
the two gels. The correlation coefficient indicating the relatedness of all the spots between 
two gels as well as the equation for a linear regression defining the indicating dots from the 
plot is shown (Fig. 4). The IgBP(s) spots from the gels generated by M. haemolytica grown 
in RPMI-1640 at 37°C and RPMI-1640 with 10% FBS showed the largest amount of 
deviation (correlation coefficient of 0.20). Neither of the remaining analysis sets had a 
correlation coefficient greater than 0.50. 
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Discussion 
Bacterial cell adherence to host cells is a required initial step in most bacterial 
infections and ECMBPs may play an important role in this process. ECMBPs may be 
required for infection. The S. aureus FnbpA is known to bind Fg as well as Fn (Wann et al., 
1999), and FnbpA has been shown to be involved in adherence to epithelial cells (Mongodin 
et al., 2002). The mechanism used by M. haemolytica to adhere to the URT in colonization 
is not known. Whereas M. haemolytica ST2 is most frequently found as a commensal of the 
nasopharynx, ST1 is most frequently isolated in infection. This change is initiated by stress 
and possibly involves a change in the host environment. Results here indicatde that the M 
haemolytica IgBP binds Fg and Fn. Fibrinogen and Fn are involved in bacterial cell adhesion 
as extracellular matrix proteins and experiments indicate a role for ECMBPs in bacterial 
adhesion to host cells. Up to 19.9 % of M. haemolytica membrane proteins were lgBPs in 
conditions modeling in vivo conditions which could indicate an important IgBP role in 
virulence. The M. haemolytica IgBP(s) might play a role in adherence and colonization. 
Additional roles for ECMBPs in virulence are being found and as a result the M. haemolytica 
IgBP(s) may have other roles in virulence. 
Far-Western blot results demonstrated that the M. haemolytica IgBP can bind bovine 
Fc IgG and Fg as well as bovine Fc IgG and Fn simultaneously. The significance of this is 
not known. There has been no previously demonstrated virulence role that IgBPs and 
ECMBPs have in common. It is possible that the M. haemolytica IgBP(s) binds one protein 
with a higher affinity than the other proteins or that steric hindrance could result in 
preferential binding of one or more proteins, particularly when IgBP(s) expression is 
upregulated. 
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Bacterial growth in RPMI-1640 with 10% FBS resulted in the highest number of 
bacteria while the least growth occurred when bacteria were grown in RPMI-1640 at 40°C. 
However, both of these conditions resulted in the greatest and nearly equal relative IgBP 
expression. It is possible that one environmental factor trigger induces upregulation under 
both conditions or the upregulation may be due to independent factors. Regardless, bacterial 
growth or lack of growth can occur independently of IgBP expression and IgBP expression 
can be upregulated under conditions that are not optimal for growth. 
The membrane proteins were separated over a pH 3-10 range. The predominance of 
the IgBP(s) spots were identified at 24 kDa and at higher pi values. These spots were 60% of 
the IgBP(s) from M. haemolytica grown in RPMI-1640 at 37°C and 76% of the IgBP(s) from 
M. haemolytica grown in RPMI-1640 with 10% FBS. It is not known if the multiple spots of 
M. haemolytica IgBP(s) are breakdown products of one protein or consist of a number of 
different proteins. Previous research suggested that the M. haemolytica IgBP(s) may 
proteolyze with products found at approximately 20 kDa (Osmundson, 2003, manuscript in 
preparation). A number of other IgBPs have multiple binding sites for immunoglobulins 
(Moks et al., 1986; Sjôbring et al., 1989). It is possible that breakdown products bind bovine 
Fc IgG as long as the binding sites are intact. 
When M. haemolytica was grown in control media, 8.2% of membrane proteins were 
IgBP(s). Up to 19.9% of membrane proteins consisted of the IgBP(s) when grown in media 
mimicking factors of in vivo growth. The smallest increase was seen when M. haemolytica 
were grown in RPMI-1640 with 50 (xM 2,2-dipyridyl where the percentage of IgBP(s) is 1.9 
times that found in minimal media alone. These results suggest that the M. haemolytica 
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IgBP(s) may have a significant role in virulence under various growth conditions and any 
role it may play in virulence mightbe increased during M. haemolytica infection. 
Growth in both RPMI-1640 with 10% FBS and RPMI-1640 at 40°C resulted in a 
threefold increase in total IgBP pixel density and growth in RPMI-1640 with 2,2'-dipyridyl 
resulted in a twofold increase compared to IgBP expression in controlled conditions. This 
again argues for a role in the IgBP(s) in virulence. Even though there was a threefold 
increase in IgBP pixel density in the first two growth conditions, the scatter plot analysis 
indicated a differential distribution at the level of expression. The correlation coefficient of 
pixel density of individual spots from IgBP(s) grown from cells in RPMI-1640 with 10% 
FBS compared to IgBP(s) from cells grown in RPMI at 37°C was 0.2. This compares to a 
correlation coefficient of 0.4 in the same comparison in conditions involving RPMI-1640 at 
40°C and RPMI-1640 at 37°C. The average pixel density deviation of upregulated protein(s) 
was 5494.4 for IgBPs from RPMI-1640 with 10% FBS grown M. haemolytica. This same 
value for IgBPs from RPMI-1640 at 40°C was 2986.9. Therefore, both growth conditions 
resulted in similar absolute total pixel density values, but there was a larger average deviation 
in individual spot density from M. haemolytica grown in RPMI-1640 with 10% FBS. There 
is an apparent difference in the upregulation of IgBP(s) expressed in the two different growth 
conditions. 
The M. haemolytica IgBP(s) has previously been shown to bind bovine Fc IgG and to 
be immunogenic (Osmundson, 2003, manuscript in preparation). These results suggest that 
the IgBP(s) has a further role in virulence because it also binds Fg and Fn. Other bacterial 
ECMBPs are involved in cell adhesion to airway epithelial cells. Similarly, upregulation of 
IgBP(s) expression in conditions mimicking in vivo conditions further suggests an important 
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role in virulence. The M. haemolytica IgBP(s) might be an important component of an M. 
haemolytica subunit vaccine. 
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FIG. 1. Far-Western blot identifying IgBP(s) binding to Fn. (A) Lanes: 1, MW markers; 
2, Far-Western blot of SDS-PAGE of 7.0 jag isolated IgBP(s) blotted to nitrocellulose 
and bound with 300.0 ^g Fn followed by labeling with rabbit anti-Fn-HRP (1:1000); 3, 
MW markers; 4, Far-Western blot of SDS-PAGE of 10.0 ng Fn blotted to nitrocellulose 
and bound to 44.0 fig isolated IgBP(s) followed by binding to 44.0 (j.g bovine Fc IgG and 
rabbit F(ab')a anti-bovine Fc IgG-HRP; 5, SDS-PAGE of 10.0 (xg Fn 
94 
MW 1 2 3 MW 4 5 6 
•1Q4 r —159.0 184.5 
104iD 
-152.3 121 3-
-118.8 ocn qpp 
121.3- 85.9- M^-845 
68.8 
52.5 
40.0 
85.9-
" a-84.5 
•-71.0 40.0 — 
68.8- *-71.0 
52.5-
-63.7 
-46.9 28.4-
35.1 21.7 
28.4— 16.8 -
4 - 1 2 %  g e l  1 2 %  g e l  
FIG. 2. Far-Western blot identifying IgBP(s) binding to Fg. Lanes: 1, MW markers; 
2, Far-Western blot of SDS-PAGE of 10.0 (ig Fg blotted to nitrocellulose and bound 
to 7.0 gg isolated IgBP(s) followed by binding to 44.0 (ig bovine Fc IgG and rabbit 
F(ab')2 anti-bovine Fc IgG-HRP; 3, SDS-PAGE of 10.0 (xg Fg; 4, MW markers; 5, 
Far-Western blot of SDS-PAGE of 10.0 (j,g Fg blotted to nitrocellulose followed by 
binding to 44 p,g bovine Fc IgG and rabbit F(ab')z anti-bovine Fc IgG-HRP; 6 SDS-
PAGE of 10.0 ng Fg. 
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FIG. 3. 2-D SDS-PAGE gels and far-Western blot of M. haemolytica membrane proteins (50 
p,g) grown in four in vitro growth conditions. (A,B) Far-Western blots of 2-D SDS-PAGE gel 
of membrane proteins (50 |ig) labeled with 44 jag bovine Fc IgG and labeled with rabbit 
F(ab')2 anti-bovine Fc IgG-HRP (1:1000). (A) MW of spots and MW markers. 2-D SDS-
PAGE of membrane proteins (50 (xg) grown in (C) RPMI-1640 at 37°C (D) RPMI-1640 with 
50 \xM 2,2'-dipyridyl (E) RPMI-1640 with 10% FBS (F) RPMI-1640 at 40°C. Crosshairs 
mark IgBP(s) location. 
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conditions (y-axis): panel A, RPMI-1640 with 50pM 2,2'-dipyridyl; panel B, RPMI-1640 
with 10% FBS; panel C, RPMI-1640 at 40°C. 
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TABLE 1. Bacterial growth in vitro 
Growth 
Condition 
RPMI-1640 
37° C 
RPMI-1640 
50\xM 2,2'-
dipyridyl 
RPMI-1640 
with 10% 
FBS 
RPMI-1640 
40°C 
Afioo 0.60 0.54 1.12 0.31 
TABLE 2. Comparison of total IgBP expression from four in vitro growth conditions 
Growth 
Condition 
IgBP 
pixel density 
Fold-increase of 
IgBP pixel density 
% IgBP pixel density 
of total pixel density 
RPMI-1640 
at 37°C 30,393 1.00 8.2 
RPMI-1640 with 
50iiM 2,2-dipyridyl 64,265 2.11 15.8 
RPMI-1640 with 
10% FBS 94,880 3.12 16.1 
RPMI-1640 
at 40°C 96,710 3.18 19.9 
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CHAPTER 4. GENERAL DISCUSSION AND CONCLUSIONS 
This study identified an IgBP expressed by M. haemolytica. Results based on 
virulence studies of IgBPs of other organisms suggest that the M. haemolytica IgBP(s) may 
have a significant role in virulence. IgBPs are present in a number of Gram-positive and 
Gram-negative bacteria. 
Experiments in vitro and in vivo point to an IgBP role in virulence both in terms of 
evasion of the host immune response and modulation of the immune response. The M. 
haemolytica IgBP was shown to be expressed in the WCS and also to be secreted. Both 
preparations had a dominant band on SDS-PAGE at 75.0 kDa and a less intensely staining 
band at 40.2 kDa. The supernatant preparation has an additional band at 107.5 kDa. This 
band appears unique to the supernatant because isolated, concentrated IgBP in Chapter 2. 
Fig. 2 shows a number of additional bands on SDS-PAGE but no band comparable to the 
107.5 kDa band found in the supernatant. Additionally, 2-0 gel results from M haemolytica 
membrane preparations have no spots greater than 95 kDa. This additional supernatant band 
could be due to post-translational modification or perhaps an additional secreted IgBP that is 
not found in the WCS or membrane preparations. 
There are a number of possible explanations for the appearance of more than one 
IgBP band and multiple spots on SDS-PAGE and 2-D far-Western blots. IgBPs from other 
organisms have repeat binding sites for Ig. Protein A has five (Mocks et al., 1986) while 
protein G has three repeat Ig binding regions (Guss et al., 1986). It is possible that the 
different M. haemolytica IgBP bands evident on far-Western blot are due to a single protein 
differing only in the number of Fc IgG binding sites at a particular molecular weight band. 
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Multiple bands could also be due to a unique protein in each Western blot band or the bands 
might be degradation products of one or more proteins. There is evidence for the latter 
possibility as seen by SDS-PAGE of the isolated, concentrated IgBP (Chapter 2, Fig. 2). 
Bacterial cell adherence to host cells is a required initial step in most bacterial 
infections and ECMBPs may play a large role in this process or may be required for 
infection. The S. aureus FnbpA is known to bind Fg as well as Fn (Wann et al., 2000) and 
FnbpA is involved in adherence to epithelial cells (Mongodin et al., 2002). The mechanism 
used by M. haemolytica to adhere to the URT initiating colonization is not known. M 
haemolytica ST2 is most frequently found as a commensal of the nasopharynx while ST1 is 
most frequently isolated in infection. This change is initiated by stress and possibly involves 
a change in the host environment. Results here indicate that the M. haemolytica IgBP binds 
Fg and Fn. Fibrinogen and Fn are involved in bacterial cell adhesion as extracellular matrix 
proteins and experiments indicate a role for ECMBPs in bacterial adhesion to host cells. Up 
to 19.9 % of M. haemolytica membrane proteins were IgBPs in conditions modeling in vivo 
conditions which could indicate an important IgBP role in virulence. The M. haemolytica 
IgBP(s) might play a role in adherence and colonization. Additional roles for ECMBPs in 
virulence are being found and as a result the M. haemolytica IgBP(s) may have other roles in 
virulence. 
Far-Western blot results demonstrated that the M. haemolytica IgBP bound bovine Fc 
IgG and Fg as well as bovine Fc IgG and Fn simultaneously. The significance of this is not 
known. There is no previously demonstrated virulence role that IgBPs and ECMBPs have in 
common. It is possible that the M. haemolytica IgBP(s) binds one protein with a higher 
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affinity than the other proteins or that steric hindrance could result in preferential binding of 
one or more proteins, particularly when IgBP(s) expression is upregulated. 
Several physical characteristics of the IgBP(s) determined in these experiments are 
consistent with the proposal that the IgBP(s) plays a role in virulence. First, flow cytometry 
showed the IgBP to be surface expressed on M. haemolytica (Chapter 2, Fig. 3). Surface 
expression of protein H, an Fc IgG-binding protein from Streptococcus pyogenes, reduces 
phagocytosis of the bacteria (Kihlberg, et al., 1999) and inhibites complement activation by 
blocking C3 deposition on the bacterial surface (Berge, et al., 1997). Increased protein A 
surface expression on S. aureus leads to increased inhibition of phagocytosis (Dosset, et al., 
1969). These virulence mechanisms may be active in M haemolytica. Second, this study 
identified a secreted form of the M. haemolytica IgBP. Soluble protein A reduces antibody-
dependent cellular (Rosenblatt, et al., 1977) and fixes complement in solution thus 
consuming complement components (Sjôquist and Stâlenheim, 1969). Soluble protein H 
interacts with IgG to form complement-activating complexes (Berge, et al., 1997). Thus, the 
CS IgBP may play a role in inhibiting phagocytosis and limiting complement activation as 
well as consuming soluble complement components. Additionally, convalescent cattle were 
shown to have an increased antibody response to the 70.5 kDa M. haemolytica IgBP when 
compared to naïve or acutely infected cattle (Chapter 2, Fig. 4). The increased antibody 
response in acutely infected cattle suggests that inhibiting the effectiveness of the IgBP may 
play a role in recovery. Lastly, growth in both RPMI-1640 with 10% FBS and RPMI-1640 at 
40°C resulted in a three-fold increase in total IgBP pixel density on 2-D gel analysis and 
growth in RPMI-1640 with 2,2'-dipyridyl resulted in a two-fold increase compared to IgBP 
expression in controlled conditions. When M. haemolytica was grown in control media, 
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8.2% of membrane proteins were IgBP(s). Up to 19.9% of membrane proteins consisted of 
the IgBP(s) when grown in media simulating factors of in vivo growth. The smallest increase 
was seen when M. haemolytica are grown in RPMI-1640 with 50 (iM 2,2-dipyridyl where the 
percentage of IgBP(s) was 1.9 times that found in minimal media alone (Chapter 3, Table 2). 
These results suggest that the M. haemolytica IgBP(s) may have a significant role in 
virulence under various growth conditions and any role it may play in virulence may be 
increased during M. haemolytica infection. 
The mechanism for the abrupt change from the predominance of the normal flora M. 
haemolytica ST2 to explosive growth of stress-associated ST1 is not known. However, 
change in host environmental factors due to stress is likely to play a role. There is no 
significant difference in the bovine Fc IgG SDS-PAGE banding patterns between ST1 and 
ST2 WCSs prepared with the same growth conditions. However, IgBP(s)membrane 
expression was up-regulated in growth conditions that mimic factors of in vivo growth 
during infection. If the change from the commensal ST2 to infective ST1 is due to a phase 
variation in M. haemolytica and is due to environmental factors, increased IgBP(s) 
expression may be part of that change. 
M. haemolytica ST1 is generally associated with BRD in cattle (Whitely, et al., 1992 
and (Frank, 1979) and ST2 is most frequently associated with pneumonic mannheimiosis in 
sheep (Fraser, et al., 1982). In an effort to determine whether the M. haemolytica IgBP is a 
factor in serotype-specificity of species-specific infection, far-Western blots were run to 
determine whether differences were evident between binding of bovine Fc IgG or sheep Fc 
IgG to ST1 and ST2 and whether bovine Fc IgG and sheep Fc IgG binds to all 12 serotype 
WCS preparations regardless of whether they are known to be involved in infection. 
Differences among infectious serotypes or between infectious and noninfectious serotypes 
might indicate a role for serotype-specific infection in cattle and sheep. Serotypes 1 and 2 
both bound bovine Fc IgG and they all had protein bands at 74.1 and 63.5 kDa that stain with 
similar intensity in the two serotypes (Chapter 2, Fig. 5). The 74.1 kDa band appeared 
equally dominant in these two serotypes. A 33.2 kDa band was evident in ST2 that is not 
found in ST1. It is possible that this difference is responsible for serotype-specificity of 
infection in cattle and sheep. However, the remaining serotypes expressed the 33.2 kDa 
protein band and these are not implicated in infection in cattle. This suggests that M. 
haemolytica expressed IgBPs do not play a role in serotype-specificity in infection of cattle. 
All 12 serotypes expressed an IgBP that bound bovine Fc IgG and all serotypes had similar 
banding patterns. No serotype had a protein band that is unique to that serotype. This is 
further evidence that M. haemolytica IgBP does not play a role in the dominance of ST1 
found in infections in cattle. Differences among the serotypes in binding bovine Fc IgG may 
be due to: 1) Serotypes expressing dissimilar amounts of IgBP; 2) different serotypes 
expressing IgBPs with diverse numbers of Fc IgG binding sites; or 3) M. haemolytica 
expressing more than one bovine Fc IgG IgBP in different serotypes. 
Serotype 2 bound sheep Fc IgG more intensely than does ST1 (Chapter 2, Fig. 6). 
However, as in bovine Fc IgG binding, other serotypes not known to be infective had 
protein-banding patterns as intense as found with ST 2. This would suggest that the 
difference found between ST land ST 2 is not responsible for serotype-specific infection in 
sheep. All serotypes bound sheep Fc IgG in a similar protein-banding pattern. Four serotypes 
(5, 8, 13 and 14) have a particularly dominant band at 62.1 kDa. What role if any this may 
play in bacterial virulence or lack of virulence in these serotypes is not known. 
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Interestingly, bovine Fc IgG bound to M. haemolytica IgBP in a different protein-
band pattern than sheep Fc IgG in all STs. M. haemolytica may express only one IgBP that 
has separate binding sites for sheep Fc IgG and bovine Fc IgG or M. haemolytica may 
express different proteins for binding bovine Fc IgG and sheep Fc IgG. Whether or not this 
plays any role in virulence is not known and is again doubtful because these same differences 
occur among infective serotypes and noninfective STs. 
The fact that all serotypes expressed an IgBP(s) but not all serotypes are infective 
could indicate that the IgBP(s) are not involved in virulence. However, several lines of 
evidence demonstrate that this may not be true: 1) Protein A from S. aureus (Sjoquist et al., 
1972), protein H from Streptococcus pyogenes are surface expressed. These experiments 
showed M. haemolytica IgBP(s) to be surface expressed. Protein A surface expression on 
S.aureus is involved in inhibiting phagocytosis (Dosset et al., 1969) and Protein H surface 
expression inhibits phagocytosis (Kihlberg et al., 1999). 2) Convalescent cattle showed an 
increased antibody response to M. haemolytica ST1 IgBP. 3) M. haemolytica IgBP may be a 
virulence factor in infection of cattle and sheep but may not be a factor sufficient by itself to 
cause infection. 
Bacterial growth in RPMI-1640 with 10% FBS resulted in the highest number of 
bacteria while the least growth occurred when bacteria were grown in RPMI-1640 at 40°C. 
However, both of these conditions resulted in the greatest and nearly equal relative IgBP 
expression. It is possible that one environmental factor trigger induces upregulation under 
both conditions or the upregulation may be due to independent factors. Regardless, bacterial 
growth or lack of growth can occur independently of IgBP expression and IgBP expression 
can be upregulated under conditions that are not optimal for growth. 
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Even though there was a three-fold increase in IgBP pixel density in the first two 
growth conditions the scatter plot analysis indicated a differential distribution in the level of 
expression. The correlation coefficient of pixel density of individual spots from IgBP(s) 
grown in RPMI-1640 with 10% FBS compared to IgBP(s) grown in RPMI at 37°C was 0.2 
(Chapter 3, Fig. 3) This compared to a correlation coefficient of 0.4 in the same comparison 
in condition involving RPMI-1640 at 40°C and RPMI-1640 at 37°C. The average pixel 
density deviation of upregulated protein(s) was 5494.4 for IgBPs from RPMI-1640-FBS 
grown M. haemolytica. This same value for IgBPs from RPMI-1640 at 40°C was 2986.9. 
Therefore, both growth conditions result in similar absolute total pixel density values, but 
there is a larger average deviation from the spot density of individual IgBP(s) spots grown in 
control by IgBP(s) grown in RPMI-1640 with 10% FBS. There is an apparent difference in 
the upregulation of IgBP(s) expressed in the two different growth conditions. 
Even though M. haemolytica ST2 is found as a commensal in cattle while ST1 is 
generally isolated in M. haemolytica induced BRD, there was no apparent difference in the 
bovine Fc IgG SDS-PAGE banding patterns between ST1 and ST2 WCSs prepared with the 
same growth conditions. However, IgBP(s)membrane expression was upregulated in growth 
conditions that mimic factors of in vivo growth during infection. If the change from the 
commensal ST2 to infective ST1 is due to a phase variation in M. haemolytica and is due to 
environmental factors, expression may be part of that change. 
The bovine bacterial pathogenesis in Table 1 is consistent with information 
demonstrated in bacterial infections and M. haemolytica induced BRD. 
Table 1. Bovine bacterial pathogenesis 
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Body 
Temperature 
Iron Supply Bovine 
Serum 
Fibrinogen and 
Fibronectin 
Bovine 
Fc IgG 
Nasopharynx 
(Commensal) 
Normal 
38.3-38.9°C Adequate Absent Present Absent 
URT 
(Colonization) Increasing Decreasing Absent Present Absent 
LRT 
(Infection) >40.0°C 
Iron 
Sequestered 
Serum 
Flooding 
Present Present 
The proposed IgBP role in virulence model in Table 2 is consistent with what has 
been shown about bacterial infections, BRD pathogenesis and with the results of this study. 
In this scenario, whether attachment or evasion dominates when Fn, Fg and bovine Fc IgG 
are available might depend on several factors. First, the protein bound to IgBPs would be a 
determining factor in the outcome and Fn or Fg binding would facilitate attachment while 
bovine Fc IgG binding would provide protection from the host immune response. Secondly, 
the degree of upregulation may determine which protein is bound as one protein may have a 
steric advantage or disadvantage in binding at a given expression level. Finally, the affinity 
of the IgBP(s) for a particular protein would affect which protein is bound. Perhaps in the 
LRT when serum IgG, Fn, and Fg would be abundant during infection, the IgBP(s) would 
have a greater affinity for Fc IgG than the ECMPs and evasion of the host immune response 
would be the dominant role of the IgBPs. Because pathogenesis is a process and because it is 
not likely that only one moiety of protein will be bound to IgBPs at a given time, the 
proportion of any of these proteins bound at a particular time might affect the virulence role 
of the IgBP(s). 
106 
Table 2. Proposed IgBP role in virulence 
Nasopharynx URT LRT 
(Commensal) (Colonization) (Infection) 
IgBP(s) 
Expression 
Homeostatic Increased Increased 
ECMP Binding Fn/Fg binding 
No Fc IgG binding 
Fn/Fg binding 
No Fc IgG binding 
Fn/Fg binding 
Bovine Fc IgG binding 
Function Attachment Attachment Attachment Evasion 
Future research could take a number of interesting directions. Biochemical and 
biophysical characterization of the IgBP(s) would establish similarities or dissimilarities 
between the M. haemolytica IgBP(s) and other known IgBP(s). This information could help 
to determine whether roles in virulence established for other IgBPs might also be true for the 
M. haemolytica IgBP(s). Biologically, it can be determined whether or not Fn or Fg can act 
as a bridge between the M. haemolytica IgBP(s) and airway epithelial cells thus facilitating 
adhesion. Genetic analysis would clarify whether the IgBP(s) is one protein or more than one 
protein. This work would open the door to creation of a deletion mutant lacking expression 
of the IgBP(s). Infectivity trials with the deletion mutant would help determine the 
importance of the IgBP(s) in virulence. 
In conclusion, this study identified an M. haemolytica surface expressed IgBP as well 
as a secreted IgBP. The IgBP did not appear to play a role in serotype-specificity of species-
specific infection as all serotypes bound both bovine Fc IgG and sheep Fc IgG. However, 
sheep Fc IgG binds M. haemolytica IgBP with a different protein band pattern on far-
Western blot than did bovine Fc IgG. This difference may indicate a different virulence role 
for the IgBP in cattle and sheep but more likely it may be that more than one IgBP may be 
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expressed by M. haemolytica or there are different binding sites for sheep Fc IgG and bovine 
Fc IgG. The M. haemolytica IgBP from the WCS preparation was isolated by affinity 
chromatography. Western blot results in this study showed an increased antibody response to 
M. haemolytica IgBP in cattle recovering from mannheimiosis indicating a role for the IgBP 
in protection from M. haemolytica induced BRD. The in vivo and in vitro virulence 
association of protein A and other previously identified IgBPs, the similarity in surface 
expression of protein A, protein H and M. haemolytica IgBP, the presence of a secreted M 
haemolytica IgBP and the increased immune response to M. haemolytica IgBP in 
convalescent cattle suggest a role for M. haemolytica IgBP in virulence. The M. haemolytica 
IgBP(s) bound Fg and Fn. These results suggest that the IgBP(s) has a further role in 
virulence. Other bacterial ECMBPs are involved in cell adhesion to airway epithelial cells. 
Similarly, upregulation of IgBP(s) expression in conditions mimicking in vivo conditions 
further suggests an important role in virulence. The M. haemolytica IgBP(s) might be an 
important component of an M. haemolytica subunit vaccine. 
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